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Laboratory Analysis of Staphylococcus aureus in Florida From January 1, 2003 to 
December 31, 2005 with an Emphasis on Methicillin Resistance 
 
 
Stephanie Kolar 
 
 
ABSTRACT 
 
 
The Staphylococci are gram-positive bacteria that cause infections in humans and 
can produce severe morbidity and mortality.  Methicillin resistant S. aureus (MRSA) 
isolates are resistant to all β-lactam antibiotics, such as methicillin, and cephalosporins 
making treatment of these infections more difficult.  MRSA has become prevalent 
throughout the United States, spreading in the health care setting and the community.   
The purpose of this study is to examine methicillin resistance among S. aureus 
isolates in an outpatient population in the state of Florida and asses possible associations 
between methicillin resistance and age group, gender, and geographic area.  It is 
important to define methicillin resistance in a population so that clinical practice can 
adjust to the prevalence of resistance. 
The dataset used for this analysis is a record of all the S. aureus isolates tested by 
a large lab company in the state of Florida from January 1, 2003 to December 31, 2005.  
This is the first study to asses methicillin resistance with a population based dataset and 
not patients from hospitals 
The percent of isolates that were methicillin resistant increased as year increased.  
This increase in the number of methicillin resistant isolates was significant for both the 
viii 
crude and adjusted analysis.  When treated as a continuous variable and adjusted for age 
category, gender, and county of residence the odds ratio for year is 1.446, 95% CI: 1.410- 
1.484.  In 2005, 49.7% of the isolates were methicillin resistant.  Methicillin resistance 
also varied by age category, gender, county, and region.  For age group and gender the 
differences were not large and may not be clinically significant.  However, there was 
substantial variation in methicillin resistance by region and county of residence. 
With nearly half of the S. aureus isolates being methicillin resistant, the β-lactam 
antibiotics may no longer be an ideal choice for treating S. aureus infections in Florida.   
The percentage of MRSA isolates that were resistant to trimethoprim-sulfamethoxazole, 
tetracycline, gentamycin, and rifampin was low.  These antibiotics may be feasible 
alternatives to treat outpatient S. aureus infections in Florida. 
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Introduction 
 
Background 
 
The Staphylococci are non-motile, gram-positive bacteria that can cause 
infections in humans.  They have a characteristic appearance that resembles “a bunch of 
grapes” (Ruben & Muder, 1998).  The organism has the ability to survive in distressed 
environments such as acidic conditions, high sodium concentrations, and large 
temperature variations.  It can persist on contaminated objects in the environment for 
more than a week (Daum & Seal, 2001). 
The genome of S. aureus is a circular chromosome with prophages, plasmids, and 
transposons (Lowy, 1998).  S. aureus achieves a genetic flexibility through small and 
large-scale horizontal transfer of genetic determinates (Buescher, 2005).  The genes 
responsible for antibiotic resistance are found on the chromosome or extra chromosomal 
elements.  These genes can be transferred not only between different S. aureus strains, 
but also between other gram-positive bacterial species via the extra chromosomal 
elements.   
S. aureus also produces many surface proteins, which may play an important part 
in its ability to colonize host tissue.   S. aureus produces a variety of toxins, which can 
cause proinflammatory changes in mammalian cells, toxic shock syndrome, food 
poisoning, and skin erythema and separation.  The organism also produces enzymes that 
can destroy host tissue (Lowy, 1998). 
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Staphylococci can produce severe morbidity and mortality.  The major concern 
for public health is the organisms potential to cause epidemics (Ruben & Muder 1998).  
Once established in a hospital or long term care facility, S. aureus can be difficult to 
control (Gemmell et al., 2006).  S. aureus is currently the most common cause of skin and 
soft tissue infections in the United States, with the mortality of serious infections at 
twenty to twenty five percent (Fridkin et al., 2005).   
 
Antibiotic Resistance 
Before the introduction of antibiotics the mortality rate of invasive S. aureus 
infections was about 90% and about 70% of those who were infected developed 
metastatic infections (Daum & Seal, 2001;  Fuda, Fisher, & Mobashery, 2005).  With the 
introduction of penicillin in the 1940s the spread of the organism was initially checked, 
however the first resistant isolates were found only 1-2 years later.  Penicillin resistance 
is conferred by a serine protease that hydrolyzes the β-lactam ring and inactivates the 
antibiotic.  The prevalence of penicillin resistant S. aureus rapidly increased and the 
organism caused widespread outbreaks in hospitals and nurseries.  Within 6 years of 
penicillin’s introduction the prevalence of resistance reached 25% in hospitals and in 15- 
20 years the prevalence reached 25% in the community.  Penicillin resistance continues 
to be highly prevalent and less than 5% of isolates are currently susceptible (Ruben & 
Muder, 1998; Chambers, 2001; Lowy, 1998).   
Methicillin is a synthetic penicillin that is not susceptible to hydrolysis by 
staphylococcal β-lactamase.  Methicillin was introduced in 1961 to combat penicillin 
resistant S. aureus strains(Kowalski, Berbari, & Osman, 2005).  The first methicillin 
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resistant Staphylococcus aureus (MRSA) strain was reported in the United Kingdom of 
the same year (Chambers, 2001).  Since then it has become prevalent in the Unites States 
and Europe and occurs worldwide.  Diekema et al. (2001) used data from the SENTRY 
Antimicrobial Surveillance program collected from January 1997 to December 1999 to 
characterize the prevalence of MRSA and methicillin susceptible S. aureus (MSSA) from 
52 nations across the world.  They found MRSA prevalence rates of 46% (657/ 1427) in 
the Western Pacific region, 34.2% (2455/7169) in the United States, 34.9% (682/1956) in 
Latin America, 26.3% (916/3477) in Europe, and 5.7% (81/1410) in Canada.  The 
prevalence of resistance for different countries varied within regions.  In Europe 
resistance rates ranged from <2% in Switzerland and the Netherlands to 54.4% in 
Portugal.  In the Western Pacific the prevalence ranged was from 23.6% in Australia to 
>70% in Japan and Hong Kong.  
MRSA isolates are resistant to all β-lactam antibiotics: penicillins, carbapenems, 
and cephalosporins.  The β-lactams act by interfering with the enzymes required for 
synthesizing the peptidoglycan layer of the bacterial cell wall.  Methicillin resistance is 
mediated by the penicillin binding protein PBP2a, which is encoded by the mecA gene 
(Daum & Seal 2001; Tenover, 2006).  PBP2a confers resistance to β-lactams in two 
ways.  It sterically hinders the approach to the active site and it impedes the nucleophilic 
attack by the active site serine on the β-lactam ring (Fuda et al., 2005). 
The difference in morbidity and mortality between MRSA and MSSA infections 
remains controversial.  Studies of the association of MRSA and mortality have had 
inconsistent results.  Abramson and Sexton (1999) examined the difference between 
patients with MRSA and MSSA primary blood stream infections.  They found that 
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median attributable excess length of stay was longer for MRSA patients compared to 
MSSA patients (p= 0.23) and the median attributable total cost was greater for MRSA 
infections (p= 0.43).  When examining S. aureus bacterimia (SAB) Conterno, Wey, and 
Castelo (1998) found a rate of mortality for MRSA infections that was four times that of 
those with a MSSA infection.  Romero- Vivas, Rubio, Fernandez, and Picazo (1995) 
found that methicillin-resistance was an independent predictor of mortality in those with 
SAB.  In a recent study of S. aureus bacterimia, Lodise and McKinnon (2005) found that 
those who had a MRSA infection spent 1.5 times longer in the hospital (p=0.005) and the 
cost of hospitalization was 2 times that (p=0.001) of patients who had MSSA, controlling 
for disease severity.  This study did not find a significant association between MRSA and 
mortality.  Other studies have also failed to find an association between MRSA infections 
and increased mortality (Mylotte & Tayara, 2002; Blot, Vandewoude, Hoste, & 
Colardyn, 2002). 
In a study of methicillin resistance on the outcome of patients with surgical site 
infections (SSIs) Engemann et al. (2003) found that when compared to patients with 
MSSA, MRSA patients had a significantly greater 90 day mortality rate (OR= 3.4, 95% 
CI: 1.5- 7.2), a greater duration of hospitalization (2.6 additional hospital days, p= 0.11), 
and a 1.19 fold increase in hospital charges (mean extra cost due to methicillin resistance 
$13,901, p= 0.03). 
Many MRSA strains are multi-drug resistant.  Vancomycin and teicoplanin 
belong to the glycopeptide class of antibiotics and are currently the antibiotics of choice 
for treating multi-drug resistant MRSA infections, however strains of S. aureus have been 
found that have intermediate or full resistance to vancomycin (Waldvogel, 2000; 
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Appelbaum 2006a).  Strains of S. aureus that are resistant to teicoplanin have been 
reported in France (Gemmell et al. 2006). 
The glycopeptides act by inhibiting the synthesis of the bacterial cell wall.  
Thickening of the cell wall and the transfer of genetic material are hypothesized to be the 
cause of the development of vancomycin resistance.  Vancomycin binds to the terminal 
D-alanyl-D-alanine of the bacterial cell wall precursors and inhibits cell wall synthesis.  
Resistance in vancomycin intermediate S. aureus (VISA) strains is thought to arise by the 
synthesis of extra D-alanyl- D-alanine residues, which bind vancomycin molecules and 
sequester them in the outer cell wall.  Genetic analysis suggest that the first vancomycin 
resistant S. aureus (VRSA) case occurred from the in-vivo transfer of the vancomycin 
resistant genes, vanA , from E. faecalis to a MRSA stain.  This VRSA isolate was 
resistant through changing the D-alanyl- D-alanine termination residue to D-alanyl-D-
lactate, which has a reduced affinity for vancomycin (Applebaum, 2006a).   
In 1995 and 1996, two isolates from Japan were found to have reduced 
susceptibility to vancomycin.  The first from the sputum of a 64-year-old male who 
underwent lung cancer surgery and the other from the surgical wound of a 4-month old 
infant.  Both had been treated unsuccessfully with vancomycin.  The first isolate had a 
pattern of heterogeneous resistance to vancomycin, on culture it produced sub-
populations of cells with varying degrees of resistance (Appelbaum, 2006a; Hiramatsu, 
1998). 
A 1998 study of 195 non-university and 7 university hospitals in Japan, found that 
of the 970 isolates from the non-university hospitals 1.3% had heterogeneous resistance 
6 
to vancomycin and of the 129 isolates from the university hospitals 9.3% had 
heterogeneous resistance to vancomycin (Hiramatsu, 1998). 
In June of 2002 the first VRSA isolate from the United States was identified from 
a 40-year-old man in Michigan with diabetes, peripheral vascular disease, and chronic 
renal failure.  He had been treated for prior infection with vancomycin.  Vancomycin-
resistance Enterococcus faecalis and Klebsiella oxytoca were also isolated from the 
culture of an ulcer. 
In September of 2002 another VRSA isolate was reported from a 70-year-old man 
who was morbidly obese and hypertensive in Hershey, Pennsylvania.  This patient had 
also had multiple courses of treatment with vancomycin and the culture was also from an 
ulcer.  In 2004, a third VRSA isolate was obtained from the urine sample of an elderly 
patient in New York.  Other vancomycin-resistant enterococi were also isolated from this 
patient. 
In 2005 a forth isolate was cultured from a 78-year-old man with coronary artery 
disease, diabetes, peripheral vascular disease, neuropathy, chronic renal insufficiency, 
and obstructive uropathy.  This patient had received vancomycin therapy and 
vancomycin-resistant E. faecalis was isolated from a surveillance culture (Appelbaum, 
2006b; Appelbaum, 2006a). 
The in-vitro and in-vivo conjugative transfer of vancomycin resistance from E. 
faecalis to S. aureus has been demonstrated in the laboratory setting (Noble, Virani, & 
Cree, 1992). Three of the four VRSA isolates from the U.S. have been cultured from 
patients whose cultures also grew vancomycin-resistant enterococci, only the patient 
from Hershey did not have vancomycin-resistant enterococci isolates found.  This could 
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indicate the in-vivo transfer of the vanA gene from the enterococcus to S. aureus 
(Appelbaum, 2006b; Appelbaum, 2006a). 
Using data from the SENTRY program Diekema et al. (2001) found that less than 
1% of S. aureus isolates had reduced susceptibility to Vancomycin and only one isolate 
was resistant.  There were also 5 isolates with reduced susceptibility to teicoplanin. 
Currently there are three effective drugs on the market to treat multi-drug resistant 
MRSA infections other than vancomycin.  Linezolid, which blocks the assembly of the 
initiation complex required for protein synthesis, and daptomycin, which promotes the 
efflux of potassium out of the cell, are both effective treatments for MRSA and since they 
have unique mechanisms of actions there is no cross-resistance to other antibiotics 
(Anstead & Owens, 2004).  In a open-label, randomized, multinational study conducted 
among hospitalized patients with MRSA surgical site infections to compare vancomycin 
to linezolid, significantly more patients that received linezolid were microbiologically 
cured (87% versus 48%, p= 0.0022).  Unlike vancomycin, linezolid has an oral 
formulation that is completely bioavailable and can be used on an outpatient 
basis(Weigelt, Kaafarani, Itani, & Swanson, 2004). 
Quinupristin-dalfopristin has been approved for the treatment of S. aureus, 
however due to high cost and adverse effects it is has not been widely used since 
linezolid and dapomycin have come onto the market.  There are also three other 
promising drugs currently undergoing clinical trials that should enter the market within 
the next couple of years.  Two new glycopeptides, oritavancin and dalbavancin, which 
inhibit cell-wall formation and are not affected by the vanA, vanB, and vanC encoded 
alterations that impart resistance to vancomycin.  The third drug under development is 
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tiglecycline, a glycycycline that is an analog of tetracycline.  These new drugs are also 
effective against VISA and VRSA isolates (Anstead & Owens, 2004). 
 
Transmission  
The major source of outbreaks is due to carriers.  Carriage of S. aureus is strongly 
associated with subsequent infection.  The anterior nares are the major site of carriage in 
children and adults.  The rate of nasal carriage is estimated to be from 20% to 40%.  
Vaginal carriage has also been reported and is estimated to be about 10% among pre-
menopausal women.  About 20% of the population will be prolonged carriers of S. 
aureus, 60% will be intermittent carriers, and 20% will never be colonized.  Some people 
may become colonized with several different strains at the same time (Waldvogel, 2000; 
Kuehnert et al., 2006). 
As part of the National Health and Nutrition Examination Survey, 2001- 2002, 
Kuehnert et al. (2006) examined the nasal colonization rates of 9,622 people.  The 
weighted prevalence of S. aureus colonization was 32.4% (95% CI: 30.7%- 34.1%).  
Colonization was highest among those 6-11 years of age (OR= 2.7, 95% CI: 2.0- 3.6, 
reference group: 1 to 5 year olds).  The weighted prevalence of MRSA colonization was 
0.8% (95% CI: 0.4%- 1.4%).  They found that MRSA colonization was associated with 
being female (OR= 2.0, 95% CI: 1.2- 3.4) and age greater than 60 (OR= 4.3 95% CI: 1.2- 
14.8).  No other factors investigated, such as poverty, education, birth outside the US, 
military service, health-care exposure, or presence of diabetes or dermatologic 
conditions, were found to be statistically significant. 
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Certain groups of people are more prone to carriage.  Physicians, nurses, and hospital 
ward attendants may have higher nasopharyngeal carriage rates than the general 
population.  Other groups at higher risk of carriage include; diabetics receiving insulin 
injections, those undergoing chronic hemodialysis or continuous ambulatory peritoneal 
dialysis, those with a variety of dermatologic conditions, illicit intravenous drug users, 
and HIV positive patients (Waldvogel, 2000).  Nasal carriers are predisposed to 
postoperative infection (Ruben & Muder 1998).  
From the anterior nares carriage site, the bacteria can be transferred to the skin.  
The mucous membrane and skin are an effective barrier to tissue infection.  Trauma 
provides S. aureus with a portal of entry and leads to a local or generalized infection.  In 
the case of hospitals and long term care facilities, the bacteria are usually introduced into 
an institution via an infected or colonized patient or by a colonized health care worker.  
The bacteria are then transferred from one patient to another by the hands of health care 
workers or the inanimate environment.  This has led to major epidemics in hospitals and 
other chronic care facilities (Waldvogel, 2000).  In a study of contact transmission, 
McBryde, Bradley, Whiteby, and McElwain (2004) found that 17%(9- 25%) of contacts 
between a health care worker and a patient colonized with MRSA resulted in the 
transmission of MRSA onto the gloves of the health care worker. 
Other routes of transmission have also been reported.  Embil et al. (2001) 
investigated an outbreak of MRSA on a burn unit from September 19 to November 20, 
1996.  They found that a hand held shower and stretcher for showering in the 
hydrotherapy room were culture positive for the outbreak strain of MRSA and the most 
likely route of transmission.  In an investigation of a MRSA outbreak on an Intensive 
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Therapy Unit Cotterill, Evans, and Fraise (1996) found that the source may have been the 
air-exhaust component of the isolation room’s ventilation system.  The exhaust grille for 
the ventilation system of the isolation room was in close proximity to a window above 
another patient bed.  It is hypothesized that it would be possible for particles being 
exhausted from the ventilation system to be blown into the air and through the window. 
Kluytmans et al. (1995) studied an outbreak of MRSA between November 1992 
and April 1993 affecting 27 patients and 14 health-care workers at the University 
Hospital Rotterdam, Dijkzigt, The Netherlands.  MRSA was subsequently found in a 
banana and the outbreak strain was detected in a culture of a dietary workers nares that 
had prepared food for the hematology unit.  This is the first reported incident of a food 
initiated MRSA outbreak.  In 2002, Jones et al. (2002) reported a cluster of gastroenteritis 
in a community setting.  Three adults became ill after consuming shredded pork and 
coleslaw from a convenience-market delicatessen.  The likely source of contamination 
was determined to be a food handler who was a nasal carrier of the outbreak MRSA 
strain. 
There is also growing evidence of animals as potential sources of infection.  
Potential human to animal and animal to human transmission have been reported among 
veterinary personal and pet owners (Weese et al., 2005; Weese et al., 2006; O’Mahoney 
et al., 2005; Manian, 2003).  Weese et al. (2005) investigated an outbreak of MRSA 
among veterinary personal that had worked with a neonatal foal colonized with MRSA at 
the Ontario Veterinary College Veterinary Teaching Hospital.  MRSA skin infections 
were found in three of the neonatal intensive care unit personnel and 10 of 103 other 
veterinary personnel were found to be nasaly colonized.  All of the isolates were 
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indistinguishable by pulsed field gel electrophoresis (PFGE) analysis and were classified 
as CMRSAA-5.  While it is difficult to determine the direction of transmission, it appears 
that there was transmission between humans and horses at this institution.  
Weese et al. (2006) investigated six cases of MRSA infection in 8 animals.  In 
each case a MRSA isolate with an indistinguishable PFGE pattern was isolated from at 
least one human.  All of the isolates were found to be the Canadian epidemic MRSA-2 
strain.   
Manian (2003) examined a case of MRSA in a diabetic patient and his wife who 
had repeated MRSA infections and nasal colonization despite antibiotic therapy and 
decolonization attempts.  Nares cultures of the pet dog grew MRSA with an identical 
PFGE pattern.   The recurrent MRSA infections in the patient and his wife were resolved 
once MRSA had been eradicated from the pet dog.  In this case it is likely that the dog 
served as a reservoir of MRSA, which led to repeated infections in the couple. 
O’Mahony et al. (2005) documented the recovery of MRSA from 25 animals and 
10 veterinary personnel from different locations throughout Ireland.  PFGE analysis 
showed that most of the non-equine isolates (14 dogs, one cat, one rabbit, and one seal) 
were indistinguishable from each other and from the personnel caring for the infected 
animals.  This strain was indistinguishable by PFGE analysis from the most prevalent 
MRSA strain in the Irish population.  The eight isolates from horses and the isolates from 
their personnel were indistinguishable from each other and were unlike those from the 
other animals. 
Concurrent colonization with indistinguishable PFGE patterns suggests that 
human to animal and animal to human transmission of MRSA is possible.  The 
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possibility of household pets as a reservoir of MRSA should be considered in patients 
with recurrent Community Acquired-MRSA (CA-MRSA) infections in which no other 
source can be identified (Weese et al., 2006; Manian, 2003). 
Types of Infections 
S. aureus  can cause a variety of infections.  Skin infections of S. aureus include 
folliculitis, furuncles (boils), impetigo, hydradenitis suppurativa, mastitis, wound 
infection, and spreading pyodermas.  Treatment for these localized skin infections is the 
removal of hair from the area, repeated cleansing with an antiseptic solution alternating 
with a moist dressings, and covering the infected area with a sterile dressing.  Parenteral 
vancomycin and teicoplanin may also be considered as part of the treatment for skin 
infections of MRSA if there is a high risk of serious infection such as bacteremia or 
endocarditis (Gemmell et al 2006; Waldvogel, 2000). 
Two localized infections with diffuse skin rash are Staphylococcal Scalded Skin 
Syndrome (SSSS) and Toxic Shock Syndrome (TSS).  SSSS is treated with parental 
antibiotics and supportive skin care.  TSS treatment requires aggressive fluid replacement 
followed by intravenously administered antibiotics (Waldvogel, 2000).   
S. aureus can spread to other sites including the bones, joints, kidneys, and the 
lungs.  In severe cases, infection can lead to septicemia and endocarditis.  Factors such as 
advanced age, immunosuppression, chemotherapy, and invasive procedures have been 
found to increase the risk of sepsis (Lowy, 1998).  In most instances, S. aureus 
bacteremia is the result of a localized infection gaining access to the blood stream.  
Patients initially experience chills and occasionally frank rigors.  Patients are often 
obtunded and have joint pain and more rarely pleuritic chest pain.  Antibiotics should be 
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promptly administered and in some cases endocarditis warrants surgical intervention 
(Waldvogel, 2000). 
Methicillin Resistance Patterns 
 
Diekema et al. (2004) performed a representative survey of 670 US hospitals, 
stratified by number of beds, geographic region, and teaching status to examine the 
antibiotic resistance trends for major pathogens, the frequency of outbreaks, and control 
measures.  In the 494 hospitals that responded, 36% of the S. aureus isolates were found 
to be MRSA.  There were significant differences in oxacillin resistance by region (p= 
0.0001), with higher rates of MRSA in the south.  MRSA was the most common resistant 
pathogen in US hospitals to cause outbreaks and was increasing in more than two thirds 
of the hospitals surveyed. 
Li et al. (2005b) used statewide, population-based antimicrobial susceptibility test 
data collected from both outpatients and inpatients in Hawaii to examine the 
epidemiologic trends of MRSA in the state.  Data was collected retrospectively from the 
State of Hawaii Antimicrobial Resistance Project from 2000 to 2002.  After removal of 
duplicate data 31,482 isolates remained in the analysis, of which 8,206 (26%) were found 
to be MRSA.  They found that the proportion of MRSA isolates during the study period 
was significantly higher among pediatric patients then among the adult population 
(p<0.01) and that a significantly higher proportion (p< 0.01) of the adult isolates were 
resistant to non-β-lactam antibiotics compared to the pediatric isolates.  Most of the 
pediatric isolates were susceptible to the non-β-lactam antibiotics except for 
erythromycin (24% of isolates were resistant).  They also found a significant increase in 
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the proportion of MRSA isolates, from 24% to 30% (p<0.01), among the adult population 
and an increasing, but not significant trend among pediatric patients. 
Moran et al (2006) performed a prospective prevalence study of adult patients 
who presented to hospitals in the EMERGEncy ID Net, a network of emergency 
departments in 11 US cities, to examine methicillin resistance in skin and soft tissue 
infections in August of 2004.  Of 422 patients with skin and soft tissue infections, 320 
were due to S. aureus.  Of the S. aureus isolates, 78% were methicillin resistant.  Among 
those who received antibiotics, antibiotic therapy given was not active against the 
infecting bacterium in 57% (100 of 175) of cases.  Only presence of abscess at enrollment 
was significantly associated with MRSA compared to MSSA.  Twenty seven percent of 
MRSA patients had an established risk factor for methicillin resistance.    
Community Associated MRSA 
Initially infections of MRSA were primarily a problem of hospitals, nursing 
homes, and long term care facilities.  Traditional risk factors for Health care Associated-
MRSA (HA-MRSA) infections include frequent contact with the health care 
environment, prolonged hospitalization, recent hospitalization or surgery, living in a 
long-term care facility or nursing home, advanced age, immunocompromise, dialysis, use 
of anti-microbial agents within the previous 60 days, and indwelling medical devices.  In 
the early 1980s, cases of MRSA began to emerge in the community, mostly among those 
with a history of injection drug use and other patients at high risk.  Recently, CA-MRSA 
infections have been found in adults and children who did not have exposure to hospitals 
or other established risk factors.  These infections acquired in the community are referred 
to as community-acquired MRSA (Daum & Seal, 2001; Jones, Kellum, Porter, Bell & 
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Schaffner, 2002;  Niami et al., 2003).  Certain populations in the US have been found to 
have an increased risk of CA-MRSA.  CA-MRSA outbreaks have been reported among 
IV drug users, children (particularly those in daycare), soldiers, competitive sport players, 
the disadvantaged, native Americans and Alaskan natives, prisoners, men who have sex 
with men, and the urban homeless.  Lack of hygiene and basic-infection control may 
contribute to outbreaks among these populations (Kowalski et al., 2005; Appelbaum,  
2006a). 
There are several features that distinguish CA-MRSA from HA-MRSA strains.  
CA-MRSA lacks the presence of hospital-associated risk factors.  CA-MRSA is generally 
susceptible to most antibiotics other than β-lactam antimicrobial drugs, unlike HA-MRSA 
strains that exhibit multi-drug resistance.  CA-MRSA has distinct genotypes that differ 
from the S. aureus strains commonly found in hospitals.  CA-MRSA predominantly 
carries the type IV staphylococcal chromosomal cassette mec (SCCmec), whereas HA-
MRSA carries cassettes I, II, or III.  The HA-MRSA strains typically carry a  mecA gene 
that is positioned next to other genetic elements, which confers resistance to other 
antibiotics.  The type IV SCCmec is smaller and lacks the additional genetic elements, 
which confer multi antibiotic resistance.  CA-MRSA typically carries genes encoding for 
toxins such as Pantone-Valentine leukocidin (PVL),a leukocyte-killing toxin, and many 
other staphylococcal enterotoxins.  The PVL cytotoxins can cause tissue necrosis and 
leukocyte destruction.  Pantone-Valetine leukocidin toxin is thought to contribute to the 
virulence of CA-MRSA strains (Charlebois et al., 2004; Weber, 2005; Rihn, Michaels, & 
Harner, 2005; Appelbaum, 2006b).   
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The most common clinical manifestation of CA-MRSA are furunculosis and 
cutaneous skin abscesses.  Approximately 90% of CA-MRSA infections are non-invasive 
skin and soft tissue infections.  These skin and soft tissue infections account for most of 
the morbidity of CA-MRSA, with mortality very uncommon (Kowalski, 2005; Stankovic 
& Mahajan, 2006). 
    The origins of CA-MRSA are unknown and may have arisen by different 
pathways.  Hospital strains of MRSA may be carried into the community, where they can 
then spread from person to person.  CA-MRSA may also arise de novo when the 
methicillin-resistance gene complex is acquired by a methicillin-susceptible strain of S. 
aureus (Charlebois et al., 2004).   
Naimi et al. (2003) compared HA-MRSA and CA-MRSA.  Twelve sentinel 
laboratories in Minnesota were used to identify cases of MRSA from January 1, 2000 to 
December 31, 2000.  A medical record review was conducted to determine whether they 
met the definition of health care associated or community acquired MRSA.  During the 
study period 4612 patients were identified with an S. aureus clinical culture, of these 25% 
were identified as MRSA infections.  Of the MRSA infections 131 (12%) were classified 
as community acquired, 937 (85%) as health care associated, and 32 (3%) could not be 
classified due to lack of information. 
The CA-MRSA patients were significantly younger (p<0.001) than health care 
associated patients with a median age of 23 years versus 68 years.  Race was documented 
for 72% of the CA-MRSA patients and 64% of the health care related patients.  The CA-
MRSA patients were significantly more likely to be nonwhite, OR= 3.13, 95% CI: 2.16- 
4.32. 
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The distribution of the type of clinical infections was also different between the 
community acquired and health care associated cases.  The CA-MRSA cases were 
significantly more likely to involve skin and soft tissue, OR= 4.25, 95% CI 2.97- 5.90.  
The CA-MRSA cases were also significantly less likely to be respiratory infections, OR 
= 0.22, 95% CI 0.09- 0.49 and urinary tract infections, OR = 0.04, 95% CI 0- 0.24.  The 
CA-MRSA isolates were significantly more likely to be susceptible to ciprofloxacin, 
clindamycin, gentamicin, and trimethoprim-sulfamethozazole, OR= 5.88, 95% CI 4.86- 
6.64. 
PFGE testing identified 119 distinct subtypes.  From these subtypes, five clonal 
groups containing 3 or more isolates were identified and accounted for 96% of the 
isolates.  Clonal group A accounted for 62% of the CA-MRSA isolates, but only 9% of 
the health care related ones (OR= 4.61, 95% CI 3.82- 5.16).  Clonal group B accounted 
for 14% of the CA-MRSA isolates and 2% of the health care related isolates (OR= 2.43, 
95% CI 1.61- 2.93).  Clonal group H was associated with health care related MRSA, 
accounting for 80% of the isolates in that group versus 16% of the CA-MRSA isolates 
(OR= 2.83, 95% CI 2.60- 2.97).  
Fridkin et al. (2005) used data from the MRSA Active Bacterial Core 
Surveillance project which monitored all MRSA isolates from 11 Baltimore hospitals, 
Health District 3 in greater Atlanta, and 12 sentinel hospitals in Minnesota to examine the 
incidence of endemic CA-MRSA infection, racial disparities in incidence, patterns of 
anti-microbial susceptibility, and clinical outcomes.  Surveillance was from February 
2002 to February 2003 in Baltimore, from July 2001 to January 2003 in Atlanta, and 
from January 2001 to January 2003 in Minnesota.   
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During the study period 12,553 MRSA isolates were reported.  Of these 2,107 
were classified as confirmed or probable CA-MRSA.  In Atlanta and Baltimore the 
incidence was significantly higher among those who were less than two years old, 
OR=1.51 (95% CI: 1.19- 1.92).  In Atlanta the incidence was significantly higher among 
blacks than whites, age-adjusted relative risk = 2.74 (95% CI 2.44- 3.07). 
Groom et al. (2001) used a retrospective cohort study design to examine the 
occurrence of CA-MRSA and risk factors associated with CA-MRSA compared with 
MSSA among a rural American Indian community during 1997.  They found that of the 
112 isolates 55% (62) were MRSA and 45% (50) were MSSA.  Of the 62 MRSA 
infections 74% (46) were classified as community acquired.  CA-MRSA isolates were 
more likely to be susceptible to other antibiotics than non-community acquired isolates, 
only resistance to ciprofloxacin was significant however.  No significant differences in 
risk factors were found between CA-MRSA and CA-MSSA. 
The current approach to treatment of community acquired S. aureus infections 
commonly includes the use of β-lactam antibiotics.  In communities where MRSA has 
become a significant proportion of S. aureus isolates this treatment approach may need to 
be reevaluated.  Clinicians need to consider the possibility of MRSA infection in the 
community setting and obtain material for bacterial culture to determine the susceptibility 
of the infecting organism (Fridkin et al., 2005).   
Molecular typing studies have found that in the U.S. most of the CA-MRSA 
infections are caused by two clones, USA 300 and USA 400.  These clones have also 
been associated with the Panton-Valentine leukocidin (PVL) virulence factor and the 
SCCmec type IV.  These CA-MRSA clones are typically resistant to β-lactams and 
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erythromycin, but remain susceptible to clindamycin, trimethoprin-sulfamethoxazole, and 
fluoroquinolones.  King et al. (2006) conducted active laboratory surveillance from 
August 1, 2003 to November 15, 2003 of S. aureus isolates from patients with skin and 
soft tissue infections at a 1000-bed urban hospital and its outpatient clinics in Atlanta, 
Georgia.  This hospital provides for a medically indigent inner-city population, about 
80% of which are African American. 
The isolates were defined as USA 300 or USA 400 based on PFGE or 
antimicrobial susceptibility pattern (anti-biogram) if PFGE was not available.  If the 
isolates with no PFGE were resistant to the β-lactams and erythromycin, but susceptible 
to clindamycin, trimethoprin-sulfamethoxazole, vancomycin, and fluoroquinolones they 
were classified as USA300/USA400.   
There were 389 episodes of S. aureus skin and soft tissue infection among 384 
patients, of which 72% (279) were found to be MRSA and 28% (100) were MSSA.  Of 
the 389 infections, 279 were classified as CA-MRSA and of those 87% (244) were 
classified as the USA 300/USA 400 CA-MRSA group.  When only isolates with a PFGE 
were considered (175 isolates), 91% (159) could be classified as USA 300/ USA 400.  Of 
the CA-MRSA isolates with PFGE patterns that matched the USA 300 or USA 400 
pattern, 87% (136) met the antimicrobial susceptibility pattern of resistance only to the β-
lactams and erythromycin.  Of the isolates with PFGE patterns that had a pattern other 
than the USA 300/USA 400, 88% (14 of 16 isolates) met the antimicrobial susceptibility 
pattern of HA-MRSA with resistance to the β-lactams, erythromycin, and at least one 
additional antibiotic. 
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It was also found that inadequate empirical and definitive antibiotic therapy was 
more common among the CA-MRSA group (65% inadequate empirical and 43% 
inadequate definitive) versus the MSSA group (1% and 1%).  When comparing the CA-
MRSA USA300/USA400 group to the MSSA group black race (prevalence ratio 1.53, 
95% CI: 1.16- 2.02), female sex (prevalence ratio 1.16, 95% CI: 1.02- 1.32) and previous 
hospitalization within 12 months (prevalence ratio 0.80, 95% CI: 0.66- 0.97) were found 
to be significantly associated in multivariate analysis.  In areas with a high prevalence of 
CA-MRSA non-β-lactam agents should be used as empirical therapy (King et al., 2006). 
In a study of S. aureus infections at Texas Children’s Hospital from August 1, 
2001 to July 31, 2004 Kaplan et al. (2005) found that the percentage of community 
associated S. aureus isolates that were methicillin resistant significantly increased during 
the study period, from 71.5% in 2001 to 76.4% in 2004 (p=0.008).  They also found that 
in the beginning of 2000 the percentage of CA-MRSA isolates that were the USA300 
clone was 50%.  In 2003 the percentage of CA-MRSA isolates that were USA300 was 
>90% and carried the PVL gene.  This indicates that the USA300 strain is capable of 
rapidly spreading in the community. 
 The risk factors for community acquired MRSA differ from those for health-care 
related MRSA infections.  Factors that have been associated with a higher risk for 
nosocomial acquisition of MRSA (HA-MRSA) are prolonged hospitalization, care in an 
intensive care unit, prolonged antimicrobial therapy, surgical procedures, dialysis, 
presence of an indwelling catheter, use of injectable drugs, residence in a nursing home 
or long term care facility, and close proximity to a patient in the hospital who is infected 
or colonized with MRSA (Salgado, Farr, & Calfee, 2003; Li et al., 2005b).   
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While hospital admission within the past twelve months has been identified as a 
risk factor for CA-MRSA in some populations, there have been reports of CA-MRSA in 
patients with no identifiable risk factors (Ellis, Hospenthal, Dooley, Gray, & Murray, 
2004).   
High Risk Populations 
 There have been reports of infections and outbreaks of CA-MRSA among 
children.  Hunt et al. (1998) reported four pediatric deaths due to CA-MRSA.  All four 
lacked traditional risk factors and were initially treated with a cephalosporin to which the 
MRSA strain was not susceptible.  Delayed use of an antibiotic to which the MRSA 
strain was not susceptible may have contributed to the fatal outcomes.  
 Herold et al. (1998) conducted a retrospective review of medical records to 
examine CA-MRSA in children with no predisposing risk factors admitted to the 
University of Chicago Children’s Hospital.  Cases of MRSA infection were classified as 
community acquired if they were obtained within 72 hours of admission, if they were 
obtained after 72 hours they were classified as nosocomially acquired.  Children with 
CA-MRSA were classified as those without identified risk if they lacked a traditional risk 
factor and those with an identified risk factor if they had a previous hospitalization of 
antimicrobial therapy within the previous 6 months, history of endotracheal intubation, an 
underlying chronic disorder, an indwelling venous or urinary catheter, history of surgical 
procedure, or a notation of a household contact with an identified risk factor in the 
medical record.   
From 1988 to 1990 there were 32 cases of MRSA identified and from 1993 to 
1995 there were 56 cases of MRSA identified.  For 1988 to 1990, 8 of the MRSA cases 
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were determined to be community-acquired and for 1993 to 1995, 35 of the MRSA cases 
were identified as CA-MRSA.  Only one of the cases from 1988 to 1990 lacked an 
identified risk factor while 25 of the cases from 1993 to 1995 lacked a traditional risk 
factor.  In this population the prevalence of CA-MRSA with no identified risk factors 
increased from 10 per 100,000 admissions in 1988 to 1990 to 259 per 100,000 admissions 
in 1993 to 1995.   
The clinical spectrum of disease associated with MRSA and MSSA isolates from 
1993 to 1995 was also examined.  Among children with CA-MRSA without identified 
risk none of the 22 children had bacteremia without a focus of infection and 27% (6 of 
22) had a diagnosis of abscess.  Among children with an identified risk factor 20% (2 of 
10) had bacteremia without a focus and none of the 10 had a diagnosis of an abscess. 
The distribution of clinical syndromes for CA-MRSA was also compared to CA-
MSSA.  In children with CA-MRSA without identified risk the distribution of clinical 
syndromes was similar to that of CA-MSSA.  Cellulitis and abscess were the predominate 
clinical syndromes for both CA-MRSA and CA-MSSA.   
Creech et al. (2005) examined the prevalence of S. aureus colonization in healthy 
children attending health maintenance visits in 2004.  Nasal swabs were collected from 
500 children.  They found that 36.4% (182) children were colonized with S. aureus and 
9.2% (46) were colonized with MRSA.  When compared to the prevalence rate of 
colonization in 2001, the rate in 2004 was significantly higher (p< 0.001).  The only 
significant risk factor found was having a family member that worked in a hospital (OR= 
2.0, 95% CI: 1.03- 4.1). 
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Infections of athletes, such as football players, rugby players, wrestlers, and 
fencers have been reported.  Among this group risk factors for infection that have been 
identified are skin trauma, contact with lesions of infected players, and sharing equipment 
or clothing (Barrett & Moran, 2004).  Studies of athletes suggest that players involved in 
frequent, repetitive contact are more likely to develop an infection, supporting the 
hypothesis that transmission occurs via direct person-to-person contact (Rihn et al., 
2005). 
 Kazakova et al. (2005) conducted a retrospective cohort study of 84 St. Louis 
Rams football players and staff members.  From September 1 through December 1, 2003  
8 MRSA infections were identified in 5 of 58 Rams players.  All were skin abscesses and 
developed at turf burn sites.  Only the lineman or linebacker position and body-mass 
index was significantly associated with MRSA infection, RR=10.6 (95% CI 1.3- infinity) 
and p= 0.03 .  This may be due to the frequent contact among linemen during play.  The 
outbreak strain carried the SCCmec type IV and PVL genes.  Comparison of PFGE 
patterns of the outbreak strain with those of other isolates revealed that the outbreak 
strain had an indistinguishable PFGE pattern from strains of two other professional 
football teams.  Eighty-four nasal cultures were obtained.  Of these none grew MRSA 
and 42% grew MSSA.  MSSA was also cultured from environmental samples and was 
found to have an identical PFGE pattern to isolates obtained from nasal swabs.     
Nguyen, Mascola, and Bancroft (2005) examined recurring MRSA infections 
among a college football team in Los Angeles.  Using a case-control design they found 
that sharing bars of soap and having preexisting cuts or abrasions were associated with an 
increase risk of becoming infected.  In a ‘carrier-control’ study they found that having a 
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locker near a teammate with an infection, sharing towels, and living on campus were 
associated with nasal carriage.   
In another study of college football players, Begier et al. (2004) investigated an 
outbreak of MRSA in Connecticut, which had resulted in 2 hospitalizations.  Ten case 
patients were identified from the 100 players on the team.  Of the six isolates available 
for PFGE, all had the pattern of USA 300 and carried the PVL gene.  Analysis revealed 
an increased risk among those who had cosmetically shaved the groin area (RR 9.3, 95% 
CI: 2.3- 37.6) or shared the whirlpool greater than or equal to 2 times a week (RR 12.2, 
95% CI: 1.4- 109.2).  Those who had sustained turf burns had a RR of 7.2, 95% CI: 1.0- 
54.4. 
In a retrospective cohort study of a MRSA outbreak among a high school 
wrestling team and the surrounding community Lindenmayer, Schoenfeld, O’Grady, and 
Carney (1998) found that none of the risk factors investigated (demographics, wrestling 
history, use of Jacuzzi, sharing towels or clothing, and contact with health care facilities) 
was associated with a significant increase in risk for developing a MRSA infection.  
Eleven non-wrestlers also developed MRSA infections, six had a connection with the 
high school while the other five had no known connection with the wrestling team or the 
high school.  The authors can only speculate that MRSA may be transmitted by less 
direct contact than that which occurs among wrestlers or that some unknown mode of 
transmission was responsible for the community cases. 
Military recruits are another high risk group.  Ellis et al. (2004) examined the 
prevalence and risk factors for CA-MRSA among 812 U.S. Army recruits.  Recruits had 
a nasal swab at the beginning of their training and 8- 10 weeks later.  At the first 
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sampling 3% (24) of the recruits were colonized with MRSA and 28% (229) were 
colonized with MSSA.  Antibiotic use within the previous 6 months was the only risk 
factor for CA-MRSA colonization that was significant (p=0.03).  Colonization with 
MRSA at the initial sampling was a significant risk factor for developing a soft-tissue 
infection.  During the study period 38% (9) of MRSA carriers developed soft-tissue 
infections while only 3%(8) of MSSA carriers developed infections (RR= 10.7, 95% CI 
4.6- 25.2, p< 0.001).   
Zinderman et al. (2004) investigated an outbreak of MRSA among military 
recruits at a training facility in the Southern U.S..  From August to December 2002 there 
were 235 cases of MRSA identified.  Most of the infections (73%,) occurred on an 
extremity.  Nasal swabs of 874 workers who had direct contact with recruits found that 
2.7% (24) were colonized with MRSA.  Once control measures were implemented such 
as placing antibacterial soaps at all recruit sinks, enforcing daily showers of adequate 
duration, and prohibiting sharing of personal items the outbreak subsided. 
Outbreaks of MRSA have also been reported among inmates in correctional 
facilities.  A case-control study from a minimum-security detention center in Georgia 
identified prolonged incarceration (>36 days) and outdoor work duty as risk factors for 
MRSA acquisition.  Another case-control study from a maximum-security prison 
identified previous antimicrobial use, self-draining of boils, skin laceration, washing 
clothes by hand, sharing soap, and recent arrival at the prison as risk factors for MRSA 
infection.  A case-control study from the Texas Department of Criminal Justice’s (TDCJ) 
largest intake facility identified previous skin infections and recent close contact with a 
MRSA-infected inmate as risk factors.  In 1998 TDCJ began requiring the culturing of all 
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draining skin lesions.  The proportion of S. aureus infections that were found to be 
MRSA increased from 24% in 1998 to 66% in 2002. 
The investigators of these studies identified four factors that contribute to the 
spread of MRSA in jails and prisons.  There are barriers to inmate hygiene such as 
limited access to soap due to security reasons.  Access to medical care can be held up due 
to co-payments required for care and insufficient supplies and staff.  Frequent medical 
staff turnover make providing education on proper infection-control procedures difficult 
and MRSA may not be recognized as the cause of skin infections (Tobin-D’Angelo, 
2003). 
There have also been reports of outbreaks of CA-MRSA among Native 
Americans, Alaskan natives, and Pacific islanders.  Baggett et al. (2003) conducted a 
retrospective cohort study in rural southwestern Alaska to investigate a large outbreak of 
community-onset MRSA infections and to determine the extent of the infections and 
whether the isolates were CA-MRSA.  This area of Alaska has a population of 25,000, of 
which about 85% are Alaskan Natives.  Many live in isolated villages with no running 
water.  Isolates from the microbiology laboratory records were identified from March 1, 
1999 to August 10, 2000.  The percentage of isolates that were MRSA was 82.2% (412 of 
501) for the study period.   
Through chart review there were 240 isolates recovered from 229 patients.  Of the 
240 isolates 75% (180) were MRSA, and skin infections accounted for 73% (175) of the 
isolates.  Of the 175 skin infection isolates, 86% (151) were MRSA and 14% (24) were 
MSSA (p< 0.01).  When comparing CA-MRSA with non-CA-MRSA, sex was found to 
be significantly different, OR= 2.5, 95% CI: 1.1- 5.8.   
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All of the 143 cases of MRSA skin infections during the study period were 
community onset.  There were 109 that met the definition of CA-MRSA infections.  
Seventy-six percent of the MRSA isolates from this population were community 
acquired, suggesting widespread acquisition and transmission in the community.  The 
high prevalence of methicillin resistance supports the recommendation that the β-lactams 
should not be used as first line therapy in this population.  The authors recommend that 
trimethoprim-sulfamethoxazole be used as first line therapy, with vancomycin only used 
in patients with severe infections.    
Melish et al. (2004) conducted a retrospective study of CA-MRSA infections in 
Hawaii from July 2001 to June 2003.  During the study period 1,389 patients from the 
four study facilities were identified as having MRSA, of which 389 (28%) had an illness 
that was consistent with CA-MRSA.  Racial/ethnic data was available for 346 (89%) of 
these patients.  Pacific Islanders accounted for 51% (178) of the CA-MRSA patients, but 
they made up only 24% of the population of Hawaii in 2001 (p<0.01).  In the pediatric 
and women’s center that was included in the study Pacific Islanders accounted for 
76%(90 of 118) of the CA-MRSA patients, but only 35% of the patients served by these 
centers are Pacific Islanders (p< 0.01).   
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Objectives 
The purpose of this study is to examine whether or not methicillin and the β-lactam 
class of antibiotics should continue to be used to treat Staphylococcal infections in 
Florida.  The study will examine the proportion of MRSA versus MSSA infections in 
Florida and who is becoming infected with methicillin resistant S aureus strains. The β-
lactam antibiotics are ineffective against MRSA isolates.  If the percent of S. aureus 
isolates that are methicillin resistant is high then β-lactam antibiotics may not be the ideal 
choice for initial treatment of S. aureus infections in this population.  In clinical practice 
antibiotic use needs to adjust to changes in the prevalence of resistance (Gemmell et al. 
2006).  Knowing the prevalence of resistance in Florida will allow clinicians to adapt 
treatment of S. aureus infections based on the likelihood that the strain is resistant. 
The study will also examine potential associations between gender, age, county, and 
region with regard to methicillin resistance to examine whether any subgroup of the 
population has a higher risk of having infections with methicillin resistance.  Secondary 
descriptive analysis will include examining any association between MRSA and site of 
infection (ear, eye, nasal, other, respiratory, skin and soft tissue, sinus, and sterile site) 
and how many of the isolates in the dataset have the USA300/USA400 type anti-biogram 
(the most common CA-MRSA clones in the U.S.). 
The hypothesis is that the proportion of S. aureus isolates that are methicillin resistant 
have increased from January 1, 2003 to December, 31 2005 and that there are differences 
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in those who contract methicillin-resistant versus methicillin susceptible S. aureus 
infections. 
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Methods 
 
Database 
 
The dataset is a record of all the S. aureus isolates tested by a large lab company 
in the state of Florida from January 1, 2003 to December 31, 2005.  This is the first 
statewide surveillance of both methicillin resistant and methicillin susceptible S. aureus 
and was conducted over a three year time period.  The dataset contained a large number 
of isolates.  Before exclusions there were 67,790 isolates.  This dataset consists almost 
entirely of cultures from outpatient facilities.  Only 275 of the total 67,790 isolates, 0.4%, 
were from a provider with hospital in the name.  This is in contrast to previous studies of 
MRSA that have been  based on S. aureus isolates taken from emergency room visits or 
hospitalized patients.   
Data Included and Excluded 
 
The study design of this investigation is cross-sectional since information on both 
the outcome (Methicillin resistance) and exposure (age, gender, county) was collected at 
the same point in time.  The original dataset was cleaned at the Florida Department of 
Health.  In the initial dataset the antibiotic susceptibilities that were tested for each person 
were listed down in approximately fifteen rows.  The antibiotics and the resistance 
variables were transposed in order to make each observation into one row.  First and last 
name and date of birth were used to determine if two isolates were duplicates.  If two 
observations had the same first and last name and date of birth then they were considered 
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to be the same person.  Address was not use to categorize observations as duplicates due 
to large variation in the manner in which street addresses were recorded and there is also 
the possibility that a person could have moved during the study period, which would 
cause them to be counted more than once. 
The dataset was examined manually to look for potential errors in first and last 
name and date of birth.  If it was determined that there was an error in the first and last 
name or date of birth then it was changed manually.  For all three years there were 298 
observations that were changed. 
Some patients had more than one isolate taken for testing on the same day.  A 
majority of these had the same antibiotic susceptibility profile.  For patients who had 
different susceptibilities for an antibiotic the most resistant isolate was used for the 
analysis.  
Some observations that had two isolates taken on the same day had two different 
sources.  For these observations the isolate from the more serious infection was used.  In 
nearly all of those who had two sources, one of them was a nasal swab or unknown.  The 
other source recorded was used because a nasal swab may be a test for colonization with 
MRSA and not infection.  There were only two observations that had two sources in 
which one of them was not nasal or unknown.   
As per National Committee for Clinical Laboratory Standards (NCCLS) 
guidelines, only the first isolate per person per analysis period of 365 days was used in 
the analysis.  This approach has been validated by several studies evaluating isolate 
removal methods (Horvat, Klutman, Lacy, Graver, & Wilson, 2003; Lee et al., 2004; Li 
et al., 2005; Magee, 2004; Shannon & French, 2002). It is believed that patients with a 
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methicillin resistant isolate may have repeat cultures taken more often than patients who 
have susceptible S. aureus isolates, leading to a biased resistance estimate (Magee, 2004).  
Horvat et al. (2003) found that there was a significant difference between de-duplicated 
methicillin resistance estimates and estimates including all isolates and that 91% of 
patients tested did not switch between MRSA and MSSA during the 6-year analysis 
period.  Lee et al. (2004) and Li et al. (2005) found that those with MRSA isolates had 
more duplicates then those with MSSA and including all isolates produced lower 
susceptibility estimates.  Lee et al. (2004) concluded that, “These results suggest that the 
method of calculating results for the first isolate per patient may remove the effect of 
duplication, allowing the simple and unambiguous analysis of cumulative susceptibility 
rates” (p. 4776). 
Exposure 
 
The exposures used in the analysis were gender, age, and county and region of 
residence.  Age was put into 10-year intervals of <1, 1-10, 11- 20, 21- 30, 31-40, 41- 50, 
51- 60, 61- 70, 71- 80, 81- 90, and >90.  Those who were less than one year of age were 
put into a separate category because they may have different risks than older children.  In 
the analysis age was treated as a nominal variable.  Of those who were 11 to 40, the 11 to 
20, 21 to 30, and 31 to 40 age groups, the group with the lowest resistance was selected. 
This age range was chosen because these age categories contain young healthy people. 
The 11 to 20 age group had a large number of isolates and had the lowest resistance of 
those who were 11 to 40 and was selected as the reference category.  Ten dummy 
variables were created for the eleven age categories.  In a separate analysis age was 
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divided into those who were less than 18 and those greater then or equal to 18 in order to 
compare adult and pediatric patients. 
 Counties were numbered 1 to 67 and also treated as a nominal variable.  For 
selection of the reference category, of the five counties that had the highest number of 
isolates the one with the lowest resistance was chosen.  Of the five counties with the most 
isolates, Miami-Dade County had the lowest percentage of methicillin-resistance and was 
used as the reference category.    
The state was also divided into 7 regions for analysis (Figure 1).  Region 6 was 
made the reference category because it had the lowest resistance percentage.  
 
Figure 1.  Map of the Seven Regions of Florida. 
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Outcome 
 
The outcome was whether or not the S. aureus isolate tested was methicillin 
resistant.  Resistance for all antibiotics was determined based on NCCLS standards.  
Oxacillin is used as a surrogate for methicillin resistance and was used for this purpose in 
this dataset.  If the minimum inhibitory concentration (MIC) for oxacillin of an isolate 
was less than or equal to two then the isolate was coded as susceptible, if the MIC was 
between two and four then it was coded as intermediate, and if the MIC was greater than 
or equal to 4 then it was coded as resistant.  Those that were methicillin resistant were 
considered to have the outcome.  For the analysis, antibiotic susceptibilities were coded 
as one if the isolate was resistant or had an intermediate resistance to oxacillin (a 
surrogate for methicillin resistance) and zero if the isolate was susceptible.   
Statistical Analysis 
 
Logistic regression was used to calculate odds ratios and statistical significance of 
potential risk factors for methicillin resistance to examine the association between the 
independent variables and the dependent variable.  For cross sectional studies, odds ratios 
may be calculated to evaluate statistical significance of exposure variables.  The resulting 
odds ratio is the odds of having the disease, not developing incident disease 
For the logistic regression analysis crude odds ratios were calculated for each 
variable.  A model that included gender, age category, year, and county was used to 
obtain adjusted odds ratios and 95% confidence intervals for these exposures.  In logistic 
regression any observation that has a missing variable is excluded from the analysis, so a 
crude odds ratio and 95% confidence interval were calculated for each variable including 
only those who were not missing any of the exposure variables and were included in the 
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full model.  A second model was used to calculate adjusted odds ratios for region, which 
also included gender, age category, and year to adjust for these factors.  
A second analysis of only patients with a skin and soft tissue infection was also 
conducted.  The data from this subset of patients was analyzed in the same manner as the 
complete dataset. 
To examine whether the proportion of MRSA has changed over time, the data was 
analyzed in two ways.  Year was treated as a nominal variable and two dummy variables 
were created.  The year 2003 was made the reference category because it had the lowest 
resistance percentage.  The second method was to treat year as a ordinal variable and put 
it directly into the model.  The Year 2003 was coded as 0, 2004 was coded as 1, and 2005 
was coded as 2.  This analysis was performed only including year and in a model with 
gender, age category, and county. 
Secondary Analysis 
The site from which the culture was taken, the source of the infection, was 
divided into nine categories.  Isolates which were reported to be taken from the ear were 
categorized as ear.  Isolates which were recorded as eye, cornea, conjunctiva, etc. were 
categorized as eye.  Isolates with a reported source of nasal, nose, and nostrils were 
categorized as nasal.  Isolates were categorized as other is they were from bone, urine, 
vaginal/cervical, breast fluid, semen, urethra, etc.  Isolates that were cultured from throat, 
oral, nasopharynx, and sputum were categorized as respiratory.  Isolates that were 
recorded as sinus or ethmoid were categorized as sinus.  Any isolate that had a reported 
source of arm, leg, finger, toe, etc. or ulcer, abscess, or wound were categorized as skin 
and soft tissue.  Isolates were categorized as sterile site if they were cultured from blood, 
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bursa fluid, synovial fluid, etc.  If the source was missing or the recorded data was not 
interpretable then it was categorized as unknown. 
This study also examined how many of the isolates in the dataset have the 
USA300/USA400 type anti-biogram.  If the isolate was resistant to methicillin and 
erythromycin, but susceptible to clindamycin, trimethoprim-sulfamethoxazole, 
ciprofloxacin and levofloxacin then it was considered to have the USA300/USA400 type 
anti-biogram (King et al 2006).  SAS version 9 statistical software was used for cleaning 
the raw dataset and to perform statistical analyses.   
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Results 
 
Year 
 
After removal of duplicates there were 8299 isolates for 2003, 17,309 for 2004 
and 35,986 for 2005. There were two isolates that were missing the date of service.  The 
total number of isolates after exclusions for all three years was 61,596.  
There were 8,286 isolates for 2003, 16,980 isolates for 2004, and 35,946 isolates 
for 2005 with a reported susceptibility or resistance to oxacillin and 384 observations that 
were missing a MIC for oxacillin for all three years.  These observations were not 
included in any of the analysis because they were missing the outcome variable.  The 
percentage of MRSA for all S. aureus isolates increased as year increased (Figure 2).  
The percentage of MRSA increased from 35.1% of all S. aureus isolates in 2003 to 
41.5% of isolates in 2004 to 49.7% of isolates in 2005. 
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Figure 2.  Percentage of MRSA and MSSA for all S. aureus isolates from 2003 to 2005 
For All Culture Sites. 
 
The increase was significant for both methods of analysis.  The crude odds ratio, 
when treated as a categorical variable, is 1.31, 95% CI: 1.24- 1.38 for 2004 compared to 
2003 and the odds ratio for 2005 compared to 2003 is 1.82, 95% CI: 1.73- 1.91.  When 
analyzed as a continuous variable, the crude odds ratio for year is 1.36, 95% CI: 1.33- 
1.39.  All of these confidence intervals do not include one and are significant at the α = 
0.05 level.   
The crude odds ratios excluding observations that were missing any variable were 
1.31, 95% CI: 1.24- 1.39 when comparing 2004 to 2003 and 1.84, 95% CI: 1.74- 1.95 
when comparing 2005 to 2003.  When treated as a continuous variable the odds ratio was 
1.37, 95% CI: 1.34- 1.40.  For the full logistic regression model year was included as a 
continuous variable and put directly into the model.  When included with age, gender, 
and county the odds ratio for year becomes 1.45, 95% CI: 1.41- 1.48.   
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Age Group 
There were 11 age categories, <1, 1-10, 11-20, 21-30, 31-40, 41-50, 51-60, 61-70, 
71-80, 81-90, and >90, which were numbered 0 to 10 in the analysis.  The 51-60 age 
group, category 5, had the highest number is isolates, followed by the 11-20 age group, 
category 3.  There were 901 observations that were missing patient age (Figure 3).  
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Figure 3.  Number of S. aureus Isolates for Each Age Group From 2003 To 2005 For All 
Culture Sites.  
 
When the percentage of MRSA is calculated for each age group, the missing 
category had the highest percentage of MRSA (61% in 2005). Of all the age groups, the 
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21- 30 age group has the highest percentage of MRSA (51% in 2005).  This group is 
followed by the >90 age group (50% in 2005) and the 31-40 age group (49% in 2005) 
(Figure 4).  Methicillin resistance for all the age groups and the missing group increased 
from year to year, except for the >1 age group which had a slight decrease from 2003 to 
2004, then an increase from 2004 to 2005 (Figure 5). 
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Figure 4.  Percentage of S. aureus Isolates That Were MRSA By Age Category From 
2003 To 2005 For All Culture Sites.  
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Figure 5.  Percentage of S. aureus Isolates That Were MRSA By Age Category By Year 
From 2003 to 2005 For All Culture Sites. 
 
 The missing group had the largest change in the percent of isolates that were 
resistant.  Of the age groups, the 21 to 30 year olds had the largest change in the percent 
of isolates that were resistant.  The younger age groups had a greater increase in the 
percent of isolates that were methicillin resistant (Figure 6). 
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Figure 6.  Change in the Percentage of S. aureus Isolates That Were MRSA From 2003 to 
2004 and from 2003 to 2005 By Age Group For All Culture Sites. 
 
 
For the crude odds ratios, the less than 1, 1 to 10, and 61 to 70 age groups have a 
significantly lower risk of being methicillin resistant and the 21 to 30, 31 to 40, 41 to 50, 
and the greater than 90 age groups have a significantly higher risk of being methicillin 
resistant when compared to the 11 to 20 year old reference category.  For the crude odds 
ratios excluding those missing any variable the 61 to 70 age group had significantly lower 
risk of having methicillin resistance and the 21 to 30, 31 to 40, 41 to 50, and greater than 
90 age groups have a significantly higher risk of being methicillin resistant when 
compared to the reference group (Table 3). 
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Table 3.  Crude Odds Ratios and 95% Confidence Interval for Age Categories When 
Compared to the Eleven to Twenty Age Group.  
 
Age Category OR 95% CI 
<1 0.81 0.70- 0.93
1 to 10 0.92 0.96- 0.98
11 to 20 Reference 
21 to 30 1.27 1.19- 1.37
31 to 40 1.19 1.12- 1.27
41 to 50 1.11 1.05- 1.18
51 to 60 0.97 0.91- 1.04
61 to 70 0.82 0.76- 0.88
71 to 80 0.93 0.86- 1.0
81 to 90 0.98 0.90- 1.06
>90 1.22 1.04- 1.44
 
When included in the logistic regression model with year, gender, and county, 
age, those who were 1 to 10, 51 to 60, and 61 to 70 did not have a significantly higher 
risk of having methicillin resistant S. aureus compared to methicillin susceptible S. 
aureus than those in the 11 to 20 age group.  The odds ratios and 95% confidence 
intervals for the 21 to 30, 31 to 40, 41 to 50, 71 to 80, 81 to 90, and >90 age groups all do 
not include one and have a significantly higher risk of having a methicillin resistant 
infection than the reference group at the α = 0.05 level.  The <1 age group has a 
significantly decreased risk of methicillin resistance.  The odds ratio and 95% confidence 
interval for the <1 category was less than one, this group has a significantly decreased 
risk of methicillin resistance compared to the reference group (Table 4). 
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Table 4.  Odds Ratios and 95% Confidence Interval for Age Categories When Compared 
to the Eleven to Twenty Age Group Adjusted for Gender, Year, and County. 
 
Age Category OR 95% CI 
<1 0.76 0.65- 0.88 
1 to 10 1 0.94- 1.07 
11 to 20 Reference 
21 to 30 1.19 1.10- 1.29 
31 to 40 1.21 1.13- 1.30 
41 to 50 1.14 1.06- 1.22 
51 to 60 1.04  0.94- 1.11 
61 to 70 0.93 0.86- 1.00 
71 to 80 1.1 1.01- 1.19 
81 to 90 1.13 1.04- 1.24 
>90 1.46  1.23- 1.74 
 
Adult and Pediatric 
Adults had a higher percentage of isolates that were methicillin resistant for all 
three years.  When adults were compared to pediatric patients (those less than 18), the 
crude odds ratio was 1.17, 95% CI: 1.13- 1.22.  The crude odds ratios excluding those 
missing any variable was 1.12, 95% CI: 1.08- 1.16.  The adjusted odds ratio was 1.17, 
95% CI: 1.12- 1.22.  In this dataset adults had a significantly higher risk of methicillin 
resistance than those who were under 18 (Figure 7). 
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Figure 7.  Percent of S. aureus Isolates That Were Methicillin Resistant By Adult Versus 
Pediatric By Year From 2004 To 2005 For All Culture Sites. 
 
Gender 
For the gender variable there were 34,536 males and 28,898 females.  There were 
790 observations that were missing gender.  The overall percentage of MRSA for males 
was 45.2% and the overall percentage for females was 45.7%.  When the percentage of 
MRSA for gender is divided into year, the percentage for both males and females 
increases from year to year.  However, the increase is slightly faster for females than for 
males.  In 2003, the percentage for males is slightly higher than females (35.2% for males 
and 34.9% for females), then the percentage for males and females are approximately 
even in 2004 (41.5% for males and 41.4% for females), then the percentage becomes 
slightly higher for females in 2005 (49.0% for males and 50.2% for females) (Figure 8).    
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Figure 8.  Percentage of S. aureus Isolates That Were MRSA By Year For Males and 
Females From 2003 To 2005 For All Culture Sites. 
 
The crude odds ratio is 1.022 95% CI: 0.99- 1.06.  The crude odds ratio excluding 
observations with any missing variables is 1.05, 95% CI: 1.02- 1.09.  When adjusted for 
age, county, and year, females have a slight, but significantly higher risk of having 
methicillin resistant S. aureus versus methicillin susceptible S. aureus compared to males.  
The odds ratio for females compared to males is 1.05, 95% CI: 1.01- 1.08.  When 
methicillin resistance is plotted by gender for each age group the number and percent of 
isolates that were resistant are similar for each age group and the missing group (Figure 9 
and Figure 10). 
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Figure 9.  Number of S. aureus Isolates For Each Age Group By Gender From 2003 To 
2005 For All Culture Sites. 
 
48 
Percentage of Isolates That Were 
Methicillin Resistant By Age Group 
By Gender (All Culture Sites)
0
20
40
60
80
100
>1
1 t
o 1
0
11
 to
 20
21
 to
 30
31
 to
 40
41
 to
 50
51
 to
 60
61
 to
 70
71
 to
 80
81
 to
 90> 9
0
Mi
ss
ing
Age Group
Pe
rc
en
ta
ge
Male 
Female
 
Figure 10.  Percent of S. aureus Isolates That Were Methicillin Resistant By Age Group 
By Gender From 2003 To 2005 For All Culture Sites. 
 
Region 
The state of Florida was divided into seven regions.  There were 1,531 
observations for region one (western panhandle), 6,339 for region two (central 
panhandle), 5,992 for region three (north east), 13,980 for region four (west central, 
including Tampa), 11,297 for region five (eastern central, including Orlando), 3,358 for 
region six (southwest, including Ft. Myers), 10,305 for region seven (southeast, including 
Miami), and there were 8,794 observations which were missing information on region 
(Figure 11).      
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Figure 11.  Number of Isolates For Each Region of Florida and Those That Were Missing 
Region From 2003 To 2005 For All Culture Sites. 
 
Region 1, the western panhandle, had the highest percentage of MRSA (59.9%), 
followed by the northeast, region 3 (50.5%), west central, region 4 (46.4%), eastern 
central, region 5 (44.1%), the southeast, region 7 (39.8%), central panhandle, region 2, 
(38.3%), and the southwest, region 6 (37.4%).  For the observations missing region, the 
percentage of MRSA was 54.2% (Figure 12).  The percentage of MRSA increased as 
year increased for all seven regions and the group that were missing data on region 
(Figure 13). 
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Figure 12.  Percentage of S. aureus Isolates That Were MRSA By Region of Florida 
From 2003 To 2005 For All Culture Sites. 
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Figure 13.  Percentage of S. aureus Isolates That Were MRSA By Region Of Florida By 
Year From 2003 To 2005 For All Culture Sites. 
 
 The change in the percent of isolates that were methicillin resistant was the 
highest for the southeast.  The central panhandle had the smallest change in the percent of 
isolates that were resistant (Figure 14). 
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Figure 14.  Change in the Percent of S. aureus Isolates That Were Methicillin Resistant 
From 2003 to 2004 and From 2003 to 2005 By Region Of Florida. 
 
For the logistic regression analysis, the crude odds ratios for the western 
panhandle, the northeast, West central, Eastern central, and the Southeast have a 
significantly higher risk of having methicillin resistant S. aureus strains than isolates 
from region the Southwest.  The crude odds ratios excluding those who were missing any 
variable were the same as the crude odds ratios (Table 5).  
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Table 5.  Crude Odds Ratios and 95% Confidence Interval For the Seven Regions of 
Florida Compared to Region Six. 
 
Region OR 95% CI 
Western Panhandle 2.50 2.21- 2.83 
Central Panhandle 1.04 0.95- 1.13 
Northeast 1.70 1.56- 1.86 
West Central 1.45 1.34- 1.56 
Eastern Central 1.32 1.22- 1.43 
Southwest Reference  
Southeast 1.11 1.02- 1.20 
 
 
When adjusted for gender, age, and year, the western panhandle, the Northeast, 
West central, and the Eastern central have a significantly higher risk of having methicillin 
resistant S. aureus versus methicillin susceptible S. aureus when compared to the 
Southwest (Table 6).  The risk of methicillin resistance for the Central panhandle and the 
Southeast were not significantly different than the reference category.   
 
Table 6. Odds Ratios and 95% Confidence Interval For the Seven Regions of Florida 
Compared to Region Six, Adjusted for Gender, Age, and Year. 
 
Region OR 95% CI 
Western Panhandle 2.50 2.20- 2.83 
Central Panhandle 0.97  0.89- 1.06 
Northeast 1.68 1.54- 1.84 
West Central 1.51 1.40- 1.64 
Eastern Central 1.35  1.25- 1.47 
Southwest Reference  
Southeast 1.00  0.92- 1.09 
 
County 
The number of isolates and the percent of isolates that were MRSA varied by 
county.  The number of isolates from each county, for each year, ranged from 0 to 3,654 
and the percent of isolates that were MRSA ranged from 0% to 75% (Table 7) 
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Table 7.  Percent of Isolates That Were MRSA and Total Number of Isolates For Each 
County By Year. 
 
County 
Percent of Isolates Which Were MRSA (Total Number of 
Isolates) 
 2003 2004 2005 
Alachua 51.1% (45) 57.5% (80) 62.6% (246) 
Baker 0% (7) 50% (20) 68.8% (64) 
Bay 39.7% (63) 64.9% (37) 62.4% (117) 
Bradford 33.3% (3) 40% (10) 72.2% (36) 
Brevard 25.9% (343) 43.1% (445) 49.5% (865) 
Broward 20% (5) 33.9% (1520) 42.5% (2981) 
Calhoun 40% (15) 46.7% (15) 66.7% (15) 
Charlotte 45.9% (61) 34.4% (64) 46.8% (158) 
Citrus 30% (36) 50.5% (91) 53.8% (145) 
Clay 32.7% (49) 43.2% (81) 60.2% (254) 
Collier 14.8% (27) 41.9% (31) 35.3% (85) 
Columbia 0% (9) 40% (20) 39.2% (51) 
DeSoto 33.3% (3) 25% (8) 33.3% (12) 
Dixie 58.3% (12) 64.7% (17) 40% (15) 
Duval 33.7% (496) 47.3% (763) 57.4% (2006) 
Escambia 65.6% (64) 67.1% (161) 71% (335) 
Flagler 42.9% (7) 20% (10) 50% (38) 
Franklin 20% (5) 63% (27) 60.5% (38) 
Gadsden 38.5% (26) 44.4% (18) 58.3% (36) 
Gilchrist 63.6% (11) 45% (20) 73.7% (19) 
Glades 0% (0) 0% (2) 20% (5) 
Gulf 50% (10) 57.1% (14) 75% (40) 
Hamilton 26.5% (34) 52.6% (57) 45.5% (99) 
Hardee 30.2% (43) 38.6% (44) 54.1% (98) 
Hendry 0% (6) 7.7% (13) 42.9% (56) 
Hernando 35% (103) 41.8% (165) 53% (353) 
Highlands 43.8% (16) 40.9% (22) 46.9% (32) 
Hillsborough 33.8% (1095) 42.5% (1328) 53.3% (2634) 
Holmes 33.3% (3) 0% (1) 0% (0) 
Indian River 26.4% (87) 43% (93) 43.7% (126) 
Jackson 20% (15) 50% (6) 40% (25) 
Jefferson 27.3% (11) 50% (2) 56.3% (16) 
Lafayette 0% (1) 100% (2) 33.3% (3) 
Lake 25.2% (230) 41.1% (292) 43.6% (486) 
Lee 26.7% (247) 32.5% (394) 41.6% (927) 
Leon 33.3% (60) 40.7% (86) 59.7% (124) 
Levy 35.3% (17) 54.3% (46) 45.3% (53) 
Liberty 54.5% (11) 50% (8) 66.7% (9) 
Madison 33.3% (15) 58.3% (12) 55.6% (18) 
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(Table 7 continued) 
Manatee 34.5% (249) 47.2% (320) 51.5% (618) 
Marion 32.3% (201) 42.1% (261) 50.4% (520) 
Martin 28.6% (7) 42.6% (108) 46.5% (271) 
Miami-Dade 0% (4) 29.1% (1821) 39.9% (3342) 
Monroe 0% (1) 36.2% (69) 47.2% (159) 
Nassau 35.4% (48) 44.4% (63) 52.1% (163) 
Okaloosa 51.5% (33) 63.8% (47) 53.3% (107) 
Okeechobe 20% (10) 57.1% (21) 54.8% (62) 
Orange 32.7% (740) 43.4% (1028) 50.7% (2039) 
Osceola 31.1% (161) 43.1% (255) 49.9% (487) 
Palm Beach 15.4% (26) 33.9% (1717) 42.9% (3654) 
Pasco 33.2% (328) 37.5% (453) 47% (798) 
Pinellas 38.8% (704) 49.4% (881) 53.7% (1677) 
Polk 33.8% (385) 46.4% (422) 50.2% (833) 
Putnam 31.6% (19) 35% (20) 59.3% (54) 
Santa Rosa 65% (20) 56.5% (69) 58.9% (163) 
Sarasota 25.5% (216) 35.8% (296) 39.8% (580) 
Seminole 30.9% (269) 40% (365) 50.6% (720) 
St. Johns 40.4% (47) 36.1% (61) 45.6% (125) 
St. Lucie 34.8% (112) 38.6% (166) 47.7% (405) 
Sumter 45% (40) 27.7% (65) 44.2% (52) 
Suwannee 66.7% (6) 66.7% (6) 60% (30) 
Taylor 0% (0) 50% (8) 41.7% (24) 
Union 0% (3) 66.7% (6) 46.7% (15) 
Volusia 37.4% (187) 48.1% (310) 52.2% (674) 
Wakulla 22.2% (27) 63.5% (52) 66.7% (75) 
Walton 42.9% (7) 43.5% (46) 48.3% (89) 
Washington 0% (3) 50% (2) 66.7% (3) 
Missing 45.5% (1142) 52.2% (2017) 56.7% (5587) 
 
When crude odds ratios are calculated there are 45 counties that have a 
significantly higher risk of methicillin resistance than those in the reference county, 
Miami-Dade (Table 8).  For the crude analysis excluding those who were missing any 
variable, the same 45 counties had a 95% confidence interval that did not include one 
(Not shown). 
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Table 8.  Crude Odds Ratio and 95% Confidence Interval For Counties With a 
Significantly Higher Risk of Methicillin Resistance When Compared to Miami-Dade 
County. 
 
County OR 95% CI County OR 95% CI 
Alachua 2.68 216- 3.32 Levy 1.6 1.11- 2.32
Baker 2.59 1.70- 3.95 Liberty 2.37 1.12- 5.02
Bay 2.28 1.73- 3.00 Manatee 1.56 1.37- 1.77
Bradford 3.06 1.71- 5.48 Marion 1.42 1.24- 1.64
Brevard 1.33 1.19- 1.49 Martin 1.46 1.18- 1.80
Broward 1.16 1.07- 1.26 Monroe 1.38 1.05- 1.80
Calhoun 1.86 1.03- 3.34 Nassau 1.6 1.26- 2.05
Charlotte 1.39 1.09- 1.76 Okaloosa 2.23 1.66- 2.99
Citrus 1.94 1.52- 2.48 Okeechobee 1.89 1.26- 2.86
Clay 2.01 1.63- 2.48 Orange 1.47 1.35- 1.60
Dixie 2.13 1.17- 3.87 Osceola 1.43 1.24- 1.65
Duval 1.88 1.72- 2.06 Palm Beach 1.18 1.09- 1.78
Escambia 4.01 3.32- 4.84 Pasco 1.26 1.12- 1.041
Franklin 2.51 1.56- 4.05 Pinellas 1.73 1.58- 1.89
Gadsden 1.69 1.09- 2.63 Polk 1.48 1.32- 1.65
Gilchrist 2.66 1.51- 4.70 Putnam 1.67 1.10- 2.51
Gulf 3.64 2.15- 6.15 Santa Rosa 2.53 1.95- 3.27
Hamilton 1.41 1.05- 1.88 Seminole 1.38 1.23- 1.57
Hardee 1.45 1.08- 1.94 St. Lucie 1.36 1.16- 1.60
Hernando 1.58 1.33- 1.87 Suwannee 2.89 1.54- 5.39
Hillsborough 1.53 1.41- 1.65 Volusia 1.69 1.49- 1.92
Leon 1.63 1.27- 2.08 Wakulla 2.43 1.76- 3.37
   Walton 1.54 1.10- 2.16
 
When county is included into a logistic regression model with year, gender, and 
age category, there are 50 counties whose 95% confidence interval for the odds ratio does 
not include one.  These counties have a significantly higher risk of methicillin resistance 
than the reference county, Miami-Dade, when adjusted for age, gender, and year (Table 
9).  When those who were missing data on county are put into a separate category and run 
in a model with gender, year, and age group, the odds ratio for the missing group is 2.08, 
95% CI: 1.93- 2.24.  Like 50 of the counties, the missing group has a significantly higher 
risk of methicillin resistance than the reference county. 
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Table 9.  Odds Ratio and 95% Confidence Interval For Counties With a Significantly 
Higher Risk of MRSA When Compared to Miami-Dade County. 
 
County OR 95% CI County OR 95% CI 
Alachua 2.76  2.22- 3.44 Levy 1.78 1.22- 2.59 
Baker 2.74  1.78- 4.21 Liberty 3.11 1.45- 6.64 
Bay 2.65  2.00- 3.50 Madison 2.03 1.11- 3.70 
Bradford 2.91 1.61- 5.24 Manatee 1.77 1.56- 2.01 
Brevard 1.51 1.35- 1.69 Marion 1.61 1.40- 1.86 
Broward 1.14 1.05- 1.24 Martin 1.45 1.17- 1.79 
Calhoun 2.32 1.28- 4.21 Monroe 1.37 1.05- 1.79 
Charlotte 1.53 1.19- 1.95 Nassau 1.75 1.36-2.24 
Citrus 2.13 1.66- 2.73 Okaloosa 2.46 1.82- 3.31 
Clay 2.07 1.67- 2.55 Okeechobe 1.95 1.29- 2.95 
Dixie 2.85 1.55- 5.26 Orange 1.64 1.51- 1.79 
Duval 2.01 1.84- 2.20 Osceola 1.6 1.38- 1.85 
Escambia 4.29 3.55- 5.19 Palm Beach 1.16 1.07- 1.26 
Franklin 2.81 1.73- 4.58 Pasco 1.44 1.28- 1.62 
Gadsden 1.96 1.25- 3.07 Pinellas 1.95 1.78- 2.13 
Gilchrist 3.3 1.86-, 5.87 Polk 1.71 1.52- 1.92 
Gulf 4.23 2.47- 7.24 Putnam 1.9 1.25- 2.88 
Hamilton 1.56 1.16- 2.10 Santa Rosa 2.65 2.04- 3.43 
Hardee 1.67 1.24- 2.26 Seminole 1.55 1.37- 1.76 
Hernando 1.78 1.50- 2.11 St. Johns 1.43 1.09- 1.88 
Hillsborough 1.74 1.61- 1.89 St. Lucie 1.48 1.26- 1.75 
Indian River 1.32 1.04- 1.68 Suwannee 3.01 1.60- 5.66 
Lake 1.3 1.13- 1.49 Volusia 1.83 1.61- 2.09 
Lee 1.13 1.01- 1.28 Wakulla 2.76 1.99- 3.83 
Leon 1.85 1.44- 2.37 Walton 1.56 1.11- 2.18 
 
As a comparison, an analysis using only the first per patient was performed.  
Using only the first isolate for each patient, there are 61,050 observations.  When the full 
model is run on this set of patients the results are nearly identical to using the first isolate 
every 365 days for all variables.  No odds ratio was more than 0.05 different than the 
analysis using isolates from patients every 365 days. 
 
Other Antibiotics 
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The percentage of isolates that were resistant to other antibiotics varied by year 
and by whether the isolate was MSSA or MRSA.  For MSSA isolates less than 1% of the 
isolates were resistant to amoxicillin clavuanic and about 85% were resistant to 
penicillin.  These percentages did not vary over the three years.  Nearly 100% of the 
MRSA isolates were resistant to the β-lactams amoxicillin clavuanic and penicillin.  For 
trimethoprim-sulfamethoxazole the percent that were resistant decreased slightly from 
1.5% to 0.8% among the MSSA isolates.  For the MRSA isolates the percent that were 
resistant fluctuated from 2% to 4% to 1%.  Among the quinolones and floroquinolones 
group there were differences between the MSSA and MRSA isolates.  The MSSA 
isolates had about 6% of the isolates resistant to ciprofloxacin and about 5% resistant to 
levofloxacin.  Though the resistance rate for ciprofloxacin and levofloxacin decreased 
from year to year among the MRSA isolates, the percent that were resistance was higher 
than the MSSA isolates, 39% and 36% in 2005. 
For gentamycin the percent of isolates that were resistance among the MSSA 
isolates was about 1% for the three years.  The percent that were resistant among the 
MRSA isolates was slightly higher, 2.4 % in 2005.  MRSA isolates also had a higher 
resistance rate for tetracycline, erythromycin, and clindamycin.  The percent of isolates 
that were resistant among the MRSA isolates is about double that of the MSSA isolates 
for tetracycline.  For erythromycin the percent that were resistant was about 39% among 
the MSSA isolates and 93% among the MRSA isolates.  The percent that were resistant 
to clindamycin was only 3% in the MSSA group, however among the MRSA isolates 
there were 22% that were resistant in 2003 and 2004 and 14% in 2005.  The percent that 
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were resistant to rifampin was low in both groups, <1% among the MSSA isolates and 
1% among the MRSA isolates (Table 10).   
Table 10.  Percent Resistance of MSSA and MRSA Isolates to Other Antibiotics By 
Class. 
 
Antibiotic 
  
Percent of MSSA Isolates 
 Resistant For 2003, 2004, 2005
Percent of MRSA Isolates  
Resistant For 2003, 2004, 2005
Penicillins 
Amoxicillin 
Penicillin 
  
0.7%, 0.9%, 0.3% 
84.6%, 85.1%, 84.4% 
  
99.9%, 100%, 100% 
100%, 100%, 99.9% 
Folate Pathway Inhibitors 
Trimethoprim Sulfamethoxazole 
  
1.5%, 1.3%, 0.8% 
  
2.3%, 4.1%, 1.2% 
Quinolones and Floroquinolones 
Ciprofloxacin 
Levofloxacin 
  
6.1%, 7.8%, 6.6% 
4.5%, 5.6%, 4.8% 
  
48.5%, 46.6%, 39.2% 
46.7%, 43.9%, 36.0% 
Aminoglycosides 
Gentamycin 
  
1.0%, 1.3%, 0.8% 
  
3.6%, 5.5%, 2.4% 
Tetracyclines 
Tetracycline 
  
4.2%, 6.1%, 5.2% 
  
9.9%, 12.2%, 8.9% 
Macrolides 
Erythromycin 
  
38.1%, 38.9%, 39.7% 
  
90.5%, 92.7%, 93.3% 
Lincosamides 
Clindamycin 
  
2.5%, 4.4%, 3.2% 
  
22.3%, 22.6%, 14.4% 
Rifamycins 
Rifampin 
  
0.07%, 0.7%, 0.5% 
  
1.0%, 1.7%, 1.0% 
 
Source 
In this dataset 79.6% (49,060) of the isolates were from skin and soft tissue 
infections.  The other sources each make up no more than 5% of the isolates.  There were 
1,410 isolates from the ear, 1,166 from the eye, 3,296 from nasal swabs, 568 from other 
sites, 1,910 from respiratory infections, 657 from the sinus, 289 from sterile sites, and 
3,240 that were unknown (Figure 15). 
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Figure 15.  Number of S. aureus Isolates For Each Source Site In Florida From 2003 To 
2005. 
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Figure 16.  Percent of S. aureus Isolates For Each Culture Site In Florida From 2003 To 
2005. 
 
The percentage of S. aureus isolates that were MRSA was highest for skin and 
soft tissue infections (48.9%), followed by unknown site of infection (45.5%), sterile site 
infections (37.1%), other sites of infection (36.2%), eye infections (29.5%), nasal swabs 
(28.7%), ear infections (25.8%), sinus infections (23.3%), and respiratory infections 
(21.6%) (Figure 16). 
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Figure 17.  Percentage of S. aureus Isolates That Were MRSA By Source of Infection 
From 2003 To 2005. 
 
Skin and soft tissue, other, and unknown infections increased from year to year.  
Eye and sterile site infections show an upward trend.  Ear, nasal, respiratory, and sinus 
infections did not show a clear trend over the three years (Figure 18).  Among the skin 
and soft tissue infections, MRSA accounted for 52.7% of the isolates in 2005.  This was 
the highest percent of MRSA of the nine sources.  Unknown and other isolates also had a 
high percentage of MRSA, 49.9% and 43.7% in 2005.  The percentage of MRSA in 2005 
was 39.7% for sterile site infections, 30.5% for nasal isolates, 30.4% for eye infections, 
25.8% for ear isolates, 23.9% for respiratory infections, and 23.8% for sinus infections.  
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Figure 18.  Percent of S. aureus Isolates That Were MRSA By Source By Year From 
2003 To 2005. 
 
USA300/USA400 
In 2003 there were 1,241 isolates with a USA300/USA400 type anti-biogram, in 
2004 there were 3,239, and in 2005 there were 9,360 (Figure 19).  The percent of isolates 
that had an USA300/USA400 type anti-biogram increased from 15.0% in 2003, to 19.1% 
in 2004, to 26.0% in 2005 (Figure 20). 
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Figure 19.  Number of Isolates That Had and Did Not Have A USA300/ USA400 Type 
Anti-Biogram By Year From 2003 To 2005 For All Culture Sites. 
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Figure 20.  Percent of Isolates That Had a USA300/USA400 Type Anti-Biogram By Year 
From 2003 To 2005 For All Culture Sites. 
 
There are differences in the percent of isolates that have a USA300/USA400 type 
anti-biogram by source.  The skin and soft tissue category had the highest percent of 
isolates that were the USA300/USA400 type, 28.7% in 2005.  The unknown category had 
a percent of 25.1% in 2005, among the other categories <11% of the isolates meet the 
criteria for USA300/USA400 in 2005.  Except for ear, nasal, and sterile site the percent 
of isolates that were USA33/USA400 increased from year to year (Figure 21). 
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Figure 21.  Percentage of Isolates That Had A USA300/USA400 Type Anti-Biogram By 
Source By Year From 2003 To 2005. 
 
Skin and Soft Tissue Analysis 
 There were 49,060 skin and soft tissue infections total. There were 48,876 those 
from patients from a hospital were excluded.  When this subset of patients are examined 
we find that the number and percent of isolates that were methicillin resistant increases 
from 2003 to 2005 (Figure 22 and Figure 23).  In this subset of patients the increase in 
methicillin resistance is faster than in the complete dataset, 52.7% of isolates were 
methicillin resistant in 2005. 
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Figure 22.  Number of S. aureus Isolates That Were MRSA and MSSA By Year Among 
Skin and Soft Tissue Infections. 
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Figure 23.  Percent of S. aureus Isolates That Were Methicillin Resistant By Year Among 
Skin and Soft Tissue Infections. 
 
When year is treated as a categorical variable the crude odds ratios is 1.4, 95% CI: 
1.32- 1.49 comparing 2004 to 2003 and 1.87, 95% CI: 1.76- 1.97 comparing 2005 to 
2003.  The crude odds ratio when year is treated as a continuous variable is 1.36, 95% CI: 
1.32- 1.39.  When year is added to the full model with gender, age category, and county 
the odds ratio is 1.40, 95% CI: 1.36- 1.44. 
 In this subset of patients the percent of isolates that were methicillin resistant 
increases for both males and females, but, as in the full dataset, the increases is slightly 
steeper for females.  In 2003, 36.9% of the isolates from females were methicillin 
resistant and 37.6% were resistant for males (Figure 24).  In 2004, 46.0% were resistant 
for females and 45.1% were resistant for males.  In 2005, 53.8% were resistant for 
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females and 51.6% were resistant for males.  
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Figure 24.  Percent of S. aureus Isolates That Were Methicillin Resistant By Gender By 
Year Among Skin and Soft Tissue Infections. 
 
For gender the crude odds ratio and the crude odds ratio excluding all those that 
were missing any variable were the same, OR=1.06, 95% CI:1.02- 1.10.  When included 
in the full model the adjusted odds ratio is 1.07, 95% CI: 1.03- 1.12.  As in the full 
dataset we see a slightly higher, but significant, risk for females compared to males. 
 There was an increase in the percent of isolates that were methicillin resistant for 
all age groups.  The less than one age group had very few isolates in 2003 and 2004, 3 
and 10 respectively.  The number increased to 560 in 2005.  The same trend in methicillin 
resistance by age group that is seen in the full dataset also occurs in this subset of 
patients.  The missing category had the highest percent of isolates that were methicillin 
resistant (63% in 2005).  The 21 to 30 age group had the highest percent resistant of the 
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age groups (59% in 2005) followed by the 1 to 10 age group (57.5% in 2005) and the 31 
to 40 age group (57% in 2005) (Figure 26).   
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Figure 25.  Number of Isolates For Each Age Category By Year For Skin and Soft Tissue 
Infections 
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Figure 26.  Percent of S. aureus Isolates That Were Methicillin Resistant By Age Group 
By Year Among Skin and Soft Tissue Infections. 
 
The odds ratios that were significant for the crude analysis were also significant 
for the crude odds ratios that did not include those who were missing any variable.  In the 
crude analysis those who were 1 to 10, 21 to 30, and 31 to 40 had a significantly higher 
risk and those who were 41 to 50, 51 to 60, 61 to 70, 71 to 80, and 81 to 90 had a 
significantly lower risk of methicillin resistance than the reference category, the 11 to 20 
age group (Table 11). 
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Table 11.  Crude Odds Ratios and 95% Confidence Interval For Each Age Group 
Compared to The Reference Group For Skin and Soft Tissue Infections. 
 
Age Category OR 95% CI 
<1 1.04 0.877- 1.23 
1 to 10 1.17 1.09- 1.25 
11 to 20 Reference  
21 to 30 1.25 1.16- 1.35 
31 to 40 1.15 1.07- 1.23 
41 to 50 1.04 0.97- 1.11 
51 to 60 0.87 0.82- 0.94 
61 to 70 0.73 0.67- 0.79 
71 to 80 0.8 0.74- 0.87 
81 to 90 0.84 0.77- 0.92 
>90 0.99 0.83- 1.18 
 
When adjusted for year, gender, and county the 1 to 10, 21 to 30, and 31 to 40 age 
groups have a significantly higher risk of methicillin resistance.  Only the 61 to 70 age 
group has a significantly lower risk of methicillin resistance than the reference category 
for the adjusted odds ratios (OR= 0.83, 95% CI: 0.76- 0.90). 
Table 12.  Adjusted Odds Ratios and 95% Confidence Interval For Each Age Group 
Compared to The Reference Group For Skin and Soft Tissue Infections. 
 
Age Category OR 95% CI 
<1 0.98 0.82- 1.17 
1 to 10 1.21 1.12- 1.31 
11 to 20 Reference  
21 to 30 1.16 1.06- 1.26 
31 to 40 1.15 1.06- 1.24 
41 to 50 1.06 0.98- 1.14 
51 to 60 0.93 0.86- 1.01 
61 to 70 0.83 0.76- 0.90 
71 to 80 0.94 0.86- 1.02 
81 to 90 0.96 0.87- 1.06 
>90 1.19 0.99- 1.44 
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In this subset the crude odds ratio for adult versus pediatric is 0.93, 95% CI: 0.89- 
0.97 and the crude odds ratio excluding those who were missing any variable is 0.88, 
95% CI: 0.85- 0.93.  The adjusted odds ratio is 0.95, 95% CI:0.91- 1.00.  Unlike the 
complete dataset in which adults had a significantly greater risk of methicillin resistance, 
in this subset adults have a lower, but significant risk of methicillin resistance. 
The percent of isolates that were methicillin resistant increased from year to year 
in all seven regions.  The western panhandle (region 1), had the highest resistance for all 
three years, 64.1% of isolates were resistant in 2005.  The southwest, region 6, had the 
lowest resistance for 2004 and 2005, 42.0% of isolates were resistant in 2005.  For the 
missing category 59.0% were resistant in 2005 (Figure 27). 
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Figure 27.  Percent of S. aureus Isolates That Were Methicillin Resistant By Region By 
Year Among Skin and Soft Tissue Infections. 
 
The crude odds ratios for all the other regions were significantly higher than 
region six, the reference category (Table 13).  The crude odds ratios for the analysis 
excluding those with any missing variables were similar to the crude odds ratios, the 
same counties were significantly higher than Miami-Dade county.  The odds ratios for 
each region for the full model were also similar to the crude odds ratios, all were 
significantly higher than region 6 (Table 14). 
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Table 13.  Crude Odds Ratios and 95% Confidence Interval For Each Region For Skin 
and Soft Tissue Infections. 
 
Region OR 95% CI 
Western Panhandle 2.67 2.33- 3.06 
Central Panhandle 1.36 1.23- 1.50 
Northeast 1.81 1.65- 2.00 
West Central 1.58 1.45- 1.71 
Eastern Central 1.48 1.36- 1.62 
Southwest Reference  
Southeast 1.28 1.17- 1.40 
 
Table 14.  Adjusted Odds Ratios and 95% Confidence Interval For Each Region For Skin 
and Soft Tissue Infections. 
 
Region OR 95% CI 
Western Panhandle 2.61 2.27- 3.00 
Central Panhandle 1.28 1.16- 1.42 
Northeast 1.77 1.61- 1.95 
West Central 1.62 1.49- 1.77 
Eastern Central 1.50 1.37- 1.64 
Southwest Reference  
Southeast 1.19 1.09- 1.31 
 
 For the individual counties the number of isolates for each year ranged from 0 to 
2,886 and the percent of isolates that were resistant ranged from 0% to 100%. 
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Table 15.  Percent of Isolates That Were MRSA and Total Number of Isolates For Each 
County By Year For Skin and Soft Tissue Infections. 
 
County 
Percent of Isolates Which Were MRSA (Total Number 
of Isolates) 
 2003 2004 2005 
Alachua 33.3 % (27) 60.0% (65) 62.7% (212) 
Baker 0% (5) 62.5% (16) 72.4% (58) 
Bay 40.4% (57) 63.6% (33) 63.4% (101) 
Bradford 0% (1) 40.0% (10) 76.0% (25) 
Brevard 30.0% (243) 45.5% (332) 52.2% (691) 
Broward 100% (1) 35.9% (1191) 46.1% (2412) 
Calhoun 40.0% (10) 50.0% (12) 64.3% (14) 
Charlotte 43.2% (44) 33.3% (45) 47.7% (130) 
Citrus 48.3% (29) 56.9% (65) 52.8% (123) 
Clay 35.3% (34) 40.0% (70) 61.2% (227) 
Collier 21.4% (14) 46.2% (26) 35.2% (71) 
Columbia 0% (6) 43.8% (16) 40.0% (45) 
DeSoto 50.0% (2) 28.6% (7) 33.3% (12) 
Dixie 75.0% (8) 63.6% (11) 54.5% (11) 
Duval 37.4% (369) 49.8% (605) 59.4% (1754) 
Escambia 71.2% (52) 69.6% (135) 73.6% (288) 
Flagler 60.0% (5) 14.3% (7) 48.6% (35) 
Franklin 0% (4) 65.2% (23) 61.8% (34) 
Gadsden 57.1% (14) 46.2% (13) 55.2% (29) 
Gilchrist 75.0% (8) 56.3% (16) 82.4% (17) 
Glades 0% (0) 0% (1) 20.0% (5) 
Gulf 60% (5) 61.5% (13) 77.1% (35) 
Hamilton 34.8% (23) 56.8% (37) 51.3% (76) 
Hardee 33.3% (30) 50.0% (32) 56.5% (85) 
Hendry 0% (4) 9.1% (11) 41.7% (48) 
Hernando 35.4% (79) 41.5% (130) 52.8% (320) 
Highlands 55.5% (9) 41.2% (17) 44.0% (25) 
Hillsborough 36.8% (785) 46.0% (1016) 56.1% (2158) 
Holmes 33.3% (3) 0% (0) 0% (0) 
Indian River 22.7% (66) 46.2% (78) 45.1% (113) 
Jackson 25.0% (12) 40.0% (5) 31.6% (19) 
Jefferson 20.0% (10) 50.0% (2) 53.3% (15) 
Lafayette 0% (1) 100% (2) 33.3% (3) 
Lake 26.35 (179) 43.0% (244) 45.2% (423) 
Lee 24.1% (203) 31.9% (310) 41.0% (788) 
Leon 34.8% (46) 44.6% (74) 58.9% (107) 
Levy 42.9% (14) 50.0% (28) 46.2% (39) 
Liberty 37.5% (8) 42.9% (7) 71.4% (7) 
Madison 33.3% (12) 77.8% (9) 61.5% (13) 
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(Table 15 Continued) 
Marion 33.9% (171) 43.3% (224) 50.7% (473) 
Martin 40.0% (5) 48.8% (82) 51.2% (205) 
Miami-Dade 0% (3) 36.8% (1151) 47.0% (2313) 
Monroe 0% (0) 37.9% (58) 49.6% (139) 
Nassau 38.2% (34) 50.0% (52) 52.7% (146) 
Okaloosa 52.2% (23) 64.3% (42) 56.6% (99) 
Okeechobe 25.0% (8) 60.0% (15) 56.4% (55) 
Orange 38.4% (524) 48.7% (748) 53.7% (1690) 
Osceola 32.5% (120) 48.0% (204) 50.7% (402) 
Palm Beach 19.0% (21) 40.5% (1194) 47.0% (2866) 
Pasco 36.6% (243) 42.8% (320) 49.9% (655) 
Pinellas 39.6% (556) 51.9% (696) 54.8% (1421) 
Polk 35.5% (318) 47.9% (365) 51.9% (729) 
Putnam 37.5% (16) 38.9% (18) 59.6% (47) 
Santa Rosa 85.7% (14) 60.3% (58) 60.3% (146) 
Sarasota 25.5% (157) 38.8% (209) 41.8% (469) 
Seminole 34.4% (186) 45.2% (263) 53.1% (610) 
St. Johns 36.1% (36) 41.7% (48) 44.0% (109) 
St. Lucie 34.2% (73) 38.4% (125) 50.9% (344) 
Sumter 45.2% (31) 31.1% (45) 46.7% (45) 
Suwannee 50.0% (4) 66.7% (6) 63.0% (27) 
Taylor 0% (0) 50.0% (6) 50.0% (16) 
Union 0% (2) 66.7% (6) 50.0% (14) 
Volusia 39.5% (153) 49.8% (261) 53.1% (603) 
Wakulla 18.2% (22) 66.7% (45) 68.6% (70) 
Walton 33.3% (6) 43.6% (39) 48.8% (80) 
Washington 0% (3) 50.0% (2) 66.7% (3) 
Missing 47.7% (859) 54.6% (1560) 59.0% (4711) 
 
 For the county variable there is a difference between the crude odds ratios and the 
adjusted odds ratios.  The crude odds ratios and the crude odds ratios that did not include 
any patient with a missing variable were similar, the same counties were significantly 
higher or lower than the reference county.  For the crude odds ratios there were 24 
counties that had a significantly higher risk of methicillin resistance than the reference 
county and there were 2 counties that had a significantly lower risk than the reference 
county (Table 16).  When adjusted for age group, gender, and year there are 32 counties 
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that had a significantly higher risk of methicillin resistance compared to the reference 
county and 2 counties that had a significantly lower risk of methicillin resistance (Table 
17).  There were differences in significance for 10 of the counties between the crude and 
adjusted odds ratios.  Sarasota county has a significantly lower risk for the crude odds 
ratio, but not in the adjusted.  Hendry has a significantly lower risk in the adjusted odds 
ratio, but not the crude.  Brevard, Hardee, Hernando, Leon, Marion, Nassau, Osceola, and 
Pasco counties have a significantly higher risk of methicillin resistance when adjusted for 
year, gender, and age group, but not for the crude odds ratios. 
     
Table 16.  Crude Odds Ratios For Each County For Skin and Soft Tissue Infections 
(Counties which had an OR that included one not shown).  
 
County Odds Ratio 95% CI  County Odds Ratio 95% CI  
Alachua 1.91 1.50- 2.42 Lee 0.74 0.65- 0.84 
Baker 2.50 1.56- 4.00 Manatee 1.25 1.08- 1.44 
Bay 1.69 1.26- 2.26 Martin 1.31 1.04- 1.67 
Bradford 2.29 1.16- 4.54 Okaloosa 1.78 1.30- 2.45 
Citrus 1.49 1.13- 1.96 Orange 1.28 1.16- 1.41 
Clay 1.53 1.22- 1.91 Pinellas 1.34 1.21- 1.49 
Dixie 2.24 1.06- 4.72 Polk 1.16 1.02- 1.31 
Duval 1.54 1.39- 1.70 Santa Rosa 2.11 1.59- 2.79 
Escambia 3.37 2.73- 4.16 Sarasota 0.79 0.68- 0.93 
Franklin 1.87 1.12- 3.12 Seminole 1.19 1.04- 1.37 
Gilchrist 3.13 1.59- 6.16 Suwannee 2.13 1.09- 4.15 
Gulf 3.28 1.80- 5.99 Volusia 1.31 1.14- 1.50 
Hillsborough 1.28 1.17- 1.40 Wakulla 1.93 1.36- 2.74 
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Table 17.  Adjusted Odds Ratios For Each County For Skin and Soft Tissue Infections 
(Counties which had an OR that included one not shown). 
 
County Odds Ratio 95% CI  County Odds Ratio 95% CI  
Alachua 1.89 1.48- 2.40 Lee 0.79 0.69- 0.90 
Baker 2.53 1.57- 4.08 Leon 1.38 1.05- 1.82 
Bay 1.95 1.45- 2.62 Manatee 1.37 1.18- 1.58 
Bradford 2.11 1.06- 4.21 Marion 1.25 1.07- 1.46 
Brevard 1.25 1.10- 1.42 Martin 1.32 1.04- 1.68 
Citrus 1.63 1.24- 2.16 Nassau 1.38 1.05- 1.81 
Clay 1.55 1.23- 1.95 Okaloosa 1.997 1.45- 2.76 
Dixie 2.83 1.33- 6.00 Orange 1.38 1.25- 1.52 
Duval 1.59 1.44- 1.76 Osceola 1.27 1.08- 1.50 
Escambia 3.40 2.74- 4.21 Pasco 1.23 1.07- 1.40 
Franklin 2.01 1.19- 3.40 Pinellas 1.51 1.37- 1.68 
Gilchrist 3.64 1.84- 7.21 Polk 1.29 1.14- 1.47 
Gulf 3.46 1.86- 6.42 Santa Rosa 2.09 1.58- 2.78 
Hardee 1.41 1.01- 1.97 Seminole 1.28 1.11- 1.48 
Hendry 0.58 0.34- 0.997 Suwannee 2.18 1.11- 4.29 
Hernando 1.31 1.08- 1.57 Volusia 1.42 1.23- 1.63 
Hillsborough 1.39 1.27- 1.53 Wakulla 2.12 1.49- 3.01 
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Discussion 
 
 Methicillin resistance in S. aureus has become a problem in the state of Florida.  
In 2005, 49.7% of all S. aureus isolates in this dataset were methicillin resistant.  With 
nearly half of the 2005 S. aureus isolates having methicillin resistance, the β-lactam 
antibiotics may no longer be the ideal choice for treating S. aureus infections in Florida.   
 In this population, the percentage of MRSA isolates that were resistant to 
trimethoprim-sulfamethoxazole, tetracycline, gentamycin, and rifampin was low.  These 
results are similar to previously reported susceptibilities (Nakamura, Rohling, Shashaty, 
Lu, Tang, & Edwards, 2002; Sattler, Mason, & Kaplan 2002).  These antibiotics may be 
viable alternatives to treat S. aureus infections in Florida. 
In 2005, 98% of the MRSA isolates and 99% of the MSSA isolates remained 
susceptible to trimethoprim-sulfamethoxazole.  This antibiotic has oral and intravenous 
formulations, excellent oral bioavailability, has been used for decades, and is inexpensive 
(Ellis & Lewis, 2002).  For tetracycline, 91% of the MRSA isolates and 95% of the 
MSSA isolates remained susceptible.  Minocycline and doxycycline are two long acting 
tetracycline derivatives that also have excellent bioavilability, are well absorbed by the 
gastrointestinal tract and are inexpensive.  These two antibiotics may be possible 
alternatives for treating patients with less serious infections (Ellis & Lewis, 2002; Ruhe, 
Monson, Bradsher, & Menon, 2005).  Rifampin resistance was less than 1% in both the 
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MRSA and the MSSA groups.  If used, rifampin should be used in combination with 
another antibiotic to treat S. aureus infections (Ellis & Lewis, 2002).   
The percent of isolates that were resistant to clindamycin was 3% for the MSSA 
group and 14% for the MRSA in 2005.  However, in isolates that are clindamycin 
susceptible and erythromycin resistant, clindamycin resistance can be induced (Kowalski 
et al., 2005).  In 2005, 40% of the MSSA isolates and 93% of the MRSA isolates were 
erythromycin resistant.  For isolates that are susceptible to clindamycin and 
erythromycin, clindamycin may be considered for treatment, but in isolates that are 
erythromycin resistant clindamycin should not be used unless a D-zone disk diffusion is 
performed to test for inducible clindamycin resistance (Gemmell et al., 2006: Moran et 
al., 2006).  A D-test is not generally performed and in this population 40% of MSSA and 
93% of MRSA isolates were erythromycin resistant.  Due to a high prevalence of 
erythromycin resistance, clindamycin may not an ideal choice for initial treatment in this 
population.    
There were 25 isolates with a reported resistance to vancomycin, however the 
Vitek system that was used to asses antibiotic resistance may give false positives for 
vancomycin (Raney, Williams, McGowan, and Tenover, 2002).  It is believed this is what 
happened with these isolates and that all isolates were susceptible to vancomycin; 
however, the non-availability of an oral formulation of any glycopeptide may limit their 
use in outpatient populations (Gemmell et al., 2006). 
There was an increase in the number of isolates over the three years in the dataset. 
For each increase in year the number of isolates doubled, from 8,286 isolates in 2003 to 
16,980 isolates in 2004 to 35,946 isolates in 2005.  This may be due to a number of 
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factors.  There may be an actual increase in the number of S. aureus infections.  The 
increase in the number of isolates may also be due to other factors such as an increase in 
cultures being obtained from patients or the lab company’s market share may have 
increased during this time period.  This may also be due to a combination of an increase 
in infections and physician awareness.  There was also an increase in the percent of 
isolates that were methicillin resistant over the three years. This measure may be less 
susceptible to other extraneous variables causing a change than the number of isolates.  It 
is expected that if more cultures were obtained or the lab was receiving more isolates to 
test, that the number of MSSA and MRSA isolates would both increase and the 
percentage of methicillin resistance would not be affected.   
The increase in methicillin resistant isolates over the three years was significant.  
When treated as a categorical variable, the odds ratio for 2004 compared to 2003 was 
1.31, 95% CI: 1.24- 1.38 and the odds ratio for 2005 compared to 2003 was 1.82, 95% 
CI: 1.73- 1.91.  In this population the odds that an isolate was methicillin resistant in 
2004 was 1.3 times the odds of an isolate being methicillin resistant in 2003 and the odds 
that an isolate was methicillin resistant in 2005 was 1.8 times the odds of an isolate being 
methicillin resistant in 2003.  When treated as a continuous variable, the odds of an 
isolate being methicillin resistant increases by 36% for each year(OR= 1.36, 95% CI: 
1.33- 1.39).  When adjusted for age group, gender, and county the odds of an isolate 
being methicillin resistant increases by 45% for each year (OR= 1.45, 95% CI: 1.41- 
1.48). 
For the analysis of only skin and soft tissue infections the percent of isolates that 
were methicillin resistant was slightly higher than for the entire dataset, 52.7% of isolates 
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were resistant in 2005.  The odds that an isolate was methicillin resistant in 2004 was 
1.40 times the odds of an isolate being resistant in 2003 and the odds of resistance in 
2005 was 1.87 times the odds of being resistant in 2005.  When treated as a continuous 
variable and adjusted for gender, age, and county the odds of an isolate being methicillin 
resistant increases by 40% per year.  This is a slower increase than for the full dataset, but 
the skin and soft tissue subset had a higher percent of methicillin resistance in 2003. 
For age category, the percent of isolates which were methicillin resistant increases 
with increasing age group to the 21 to 30 year olds, then decreases with increasing age 
group to the 61 to 70 year old age group, then increases with increasing age.  The 
difference between the age group with the highest resistance, 21 to 30 year olds, and the 
age group with the lowest resistance, those less than 1, was 11%.  While some of the age 
groups had a significantly higher risk of methicillin resistance compared to the reference 
category, there was not a large difference in the percent of isolates that were methicillin 
resistant between the age groups.  Only 1.5% of the total isolates were missing data on 
age and missing values is not likely to have had a significant impact on the results.   
For the skin and soft tissue analysis, the percent of isolates that were resistant in 
2005 were different than for the full dataset.  In both datasets the missing category had 
the highest percent of isolates that were methicillin resistant and the 21 to 30 age group 
had the highest of the age groups.  In the full dataset the greater then 90 category had the 
second highest percent resistant (50% in 2005) followed by the 31 to 40 age group (49% 
in 2005).  In the skin and soft tissue subset the 1 to 10 age group had the second highest 
percent resistant (58% in 2005) followed by the 31 to 40 age group (57% in 2005).  The 
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same trend of increasing with age to the 21 to 30 age group then decreasing to the 61 to 
70 age group then increasing again is seen in both datasets.   
For the skin and soft tissue isolates the difference in the percent of isolates that 
were resistant between the age group with the highest percent resistant and the group with 
the lowest percent resistant was 15%.  In skin and soft tissue infections physicians may 
need to consider the age of the patient as those who were 61 to 90 had a lower percent of 
isolates that were resistant than the other age groups. 
The odds ratios for age group for the crude and adjusted analysis were different 
between the two datasets.  For the adjusted odds ratios in the full dataset the less than 1 
age group had a significantly lower risk of methicillin resistance and the older age groups 
(21 to 50 and 71 and older) were at significantly higher risk of methicillin resistance than 
the reference group.  In the skin and soft tissue subset the younger age groups (1 to 10 
and 21 to 40) had a significantly higher risk of methicillin resistance and the 61 to 70 age 
group had a significantly lower risk of methicillin resistance.  This difference may be due 
to a difference in risk factors between all S. aureus infections and skin and soft tissue 
infections.   
For the full dataset adults had a significantly higher risk of methicillin resistance 
compared to those under 18.  There was only a small difference in the percent of isolates 
that were methicillin resistant between adults and children.  The difference in the percent 
of isolates that were methicillin resistant was 5.8 in 2003, 8.6 in 2004, and 2.4 in 2005.  
For the skin and soft tissue infections adults had a lower but not significant risk of 
methicillin resistance, OR= 0.95, 95% CI: 0.91- 0.995. 
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Females had a slightly higher risk of methicillin resistance than males in this 
population, adjusted OR=1.05, 95% CI: 1.01- 1.08.  However, the 95% confidence 
interval was just slightly above one and with such a large dataset even the smallest 
difference can be significant.  With 49.0% of isolates resistant for males and 50.2% for 
females in 2005 there is not a large difference in methicillin resistance between the sexes.  
Only 1% difference is not clinically significant.  For gender only 1.3% of the isolates 
were missing data on gender and is not likely to have an impact on the results.  The 
results for the skin and soft tissue analysis were similar to that of the entire dataset. 
Females had a slight, but significantly higher risk of methicillin resistance, however the 
difference in the percent between males and females in 2005 was only 2.2% 
While there were some differences in methicillin resistance with regards to both 
age and gender, the differences were not substantial for the entire dataset.  Only in the 
skin and soft tissue analysis was methicillin resistance different depending on age.  Age 
may need to be considered in making initial treatment decisions for skin and soft tissue 
infections.   
The number of isolates varied greatly by region, but the population of the regions 
varies as well.  It is expected that regions with a smaller population will have fewer 
isolates.  There were a large number of isolates that were missing data on region and 
county, 14.2% of the total number of isolates.  This number of missing isolates could 
have an impact on the results if those who are missing county are not equally distributed 
among the explanatory variables or methicillin resistance.   
The percent of isolates that were methicillin resistant varied by region of the state.  
The region with the highest percent resistance, the western panhandle (region 1), was 
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22% higher than the region with the lowest resistance, the southwest (region 6).  In the 
western panhandle there is a much greater chance that an S. aureus isolate is methicillin 
resistant then in the central panhandle (region 2) and the southwest.  The odds ratio for 
region the western panhandle compared to the southwest is 2.50, 95% CI: 2.20- 2.83.  
The odds of an isolate being methicillin resistant in region the western panhandle was 2.5 
times greater than that of region the southwest.   
The skin and soft tissue subset was comparable to the entire dataset.  The percent 
of isolates that were methicillin resistant was similar for the seven regions.  For the skin 
and soft tissue analysis, all the regions had a significantly higher risk of methicillin 
resistance compared to southwest.  In the entire dataset however, the central panhandle 
and the southeast were not significantly different than southwest. 
Geographic area was further divided into county.  The number of isolates for each 
county ranged from 4 isolates in Holmes to 5,486 in Palm Beach.  There are differences 
in the populations of the 67 counties and the larger counties are expected to have more 
isolates (Appendix 1). 
  In 2005, the percentage of isolates that were methicillin resistant varied from 
20% to 75% among the counties.  However, some of the counties had a small number of 
isolates.  Glades County had the lowest resistance in 2005 (20%), but there were only 5 
isolates from this county.  Gulf County had the highest percent of resistant isolates 
(75%), but there were only 40 isolates.  In counties with small numbers of isolates, it is 
likely that there will be more random variation then in the counties with larger numbers 
of isolates.  The smaller counties may have few providers that use the lab company which 
provided the data, which could have influenced sampling in these counties.  The very 
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high or low percentage of methicillin resistance could be due to random variation or 
sampling variations in some counties, particularly those with small numbers of isolates.   
There were some counties with a high percentage of MRSA that did have larger 
numbers of isolates.  In Alachua county, 62.6% of the 246 isolates were methicillin 
resistant.  In Escambia county, 71.0% of the 335 isolates were methicillin resistant.  In 
counties such as Alachua, Baker, Bay, Bradford, Clay, and Franklin, where the percent of 
isolates that were methicillin resistant was greater than 60%, there is a 60% chance that if 
a β-lactam antibiotic is used as first line therapy it will be ineffective.  In Escambia and 
Gulf counties there is a 70% chance that the infection will be resistant to a β-lactam 
antibiotic.  For most of the counties the percent of isolates that were resistant was in the 
40% to 50% range.  In 35 of the 67 counties (52%), the percent of isolates that were 
methicillin resistant was 50% or greater.  Methicillin resistance is a problem in all the 
counties and clinicians in Florida need to be aware of methicillin resistance and consider 
it when deciding on treatment options. 
For the skin and soft tissue dataset there were fewer counties (16) that were 
significantly different than the reference county.  Unlike the entire dataset in which all 
the counties that were significantly different had a higher risk of methicillin resistance, in 
the skin and soft tissue analysis there were two counties that had a significantly lower 
risk of methicillin resistance when adjusted for age, gender, and year (Hendry and Lee 
Counties).  In the full dataset Lee was significantly higher than the reference county and 
Hendry was not significantly different.  In this subset the number of isolates for each 
county ranged from 0 to 2,886 and the percent that were methicillin ranged from 0% to 
100%.  The counties with 0% and 100% had very few isolates (1 to 5).  Some counties 
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with a high percentage of MRSA had larger number of isolates.  In Alachua, Bay, Clay, 
and Santa Rosa greater than 60% of the 100 or more isolates were methicillin resistant. 
Like region, there were 14.2% of isolates that were missing data on county.  This 
could cause a bias and have an impact on the results if not evenly distributed between the 
counties and methicillin resistance. 
As part of secondary analysis, data on source of infection and whether isolates 
had a USA300/USA400 type susceptibility profile were also examined.  Most of the 
isolates in the full dataset were from skin and soft tissue infections, nearly 80%.  Among 
the different sources, the percent that were resistant to methicillin varied.  The difference 
in the percent resistant between the highest resistance, skin and soft tissue infections, and 
the lowest resistance, respiratory infections, was 28%.  This indicates that there could be 
a difference in the percent of methicillin resistance depending on the source of the 
infection and this should also be taken into account when deciding on antibiotic therapy. 
The USA300/USA400 type of isolate is associated with community acquired 
MRSA.   In this dataset there were few isolates that had this type of antibiogram.  Of the 
nine sources, skin and soft tissue isolates had the highest percent of USA300/USA400 
type isolates, 38.7% in 2005.  For all sources there was an increase in the percent of 
isolates that had a USA300/USA400 type antibiogram, potentially indicating an increase 
in CA-MRSA.  In this analysis PFGE was not performed, therefore it is uncertain 
whether these isolates actually were USA300/USA400 strains. 
Li et al. (2005b) used statewide, population-based antimicrobial susceptibility test 
data collected from both outpatients and inpatients in Hawaii from 2000 to 2002.  They 
included 31,482 isolates of S. aureus in the analysis, of which 23,550 were from 
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outpatients.  In their dataset, the proportion of MRSA was much lower than in the current 
study, 22% for outpatients and 39% for inpatients.  As in the current study they also 
found a significant increase in the proportion of MRSA during their 3-year study period.  
Most of the outpatient MRSA isolates were from skin and soft tissue infections.  Among 
pediatric outpatients 95% MRSA isolates were from wounds and among the adult 
outpatients 80% were from wounds.  In the current study 79.6% of all isolates were 
classified as skin and soft tissue infections. 
Moran et al (2006) performed a prospective prevalence study of adult patients 
who presented to hospitals in the EMERGEncy ID Net in August of 2004.  Of the 320 S. 
aureus skin and soft tissue infections, 78% were methicillin resistant.  All patients were 
seen in an emergency department.  Among this population 49% of patients were non-
Hispanic black, 25% were non-Hispanic white, 22% were Hispanic, and 4% were other 
races.  This population of ER patients may not be indicative of the entire population of 
the United States. 
This is the first study to use a large outpatient dataset to asses methicillin 
resistance in Florida.  Many previous studies have been conducted on patients in the 
hospital.  These two populations may not be the same.  Patients in the hospital may be 
different than patients attending outpatient clinics.  Those in the hospital may have more 
severe S. aureus infections, co-morbid conditions, different risk factors for methicillin 
resistance, and different demographics.   
The prevalence of MRSA also varies with geographic region (Nakamura et al., 
2002).  There have been no previous studies of S. aureus conducted in Florida and one 
cannot generalize rates from one area to another.  For physicians treating outpatients in 
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Florida, data from this study may be more appropriate for basing treatment decisions on 
because previous studies used different populations in different geographical areas and 
this is the most recent data. 
There are several limitations to this study.  First, data on other factors such as 
race, economic status, and known risk factors for methicillin resistance was not collected 
by the laboratory that conducted the resistance testing.  Therefore these variables were 
not in the dataset and could not be included in the analysis.  There is the possibility that 
potential confounding factors and other risk factors not included in the dataset could be 
causing the associations between year, age, gender, region, and county.  Second, there 
were some patients in the dataset that were missing information on the exposure or 
outcome variables.  In the complete regression model, there were 9,643 observations that 
were excluded because they were missing one or more variables.  This still leaves 51,953 
isolates for analysis, but if those who were missing data differed from those who were not 
then the results may not accurately reflect the true associations in this population.  There 
is also the possibility of data entry error on the part of the lab company.  There were 
some sources recorded which made no sense and must have been typed wrong.  There is 
the possibility that this also occurred with other variables.  However, it is unlikely that 
this would have occurred differentially among the patients and led to a bias.  This was 
also a laboratory only analysis.  This population may not represent everyone in the state.   
Further studies are needed to assess other explanatory variables such as known 
risk factors (prolonged hospitalization, care in an intensive care unit, prolonged 
antimicrobial therapy, surgical procedures, dialysis, presence of an indwelling catheter, 
use of injectable drugs, residence in a nursing home or long term care facility, and close 
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proximity to a patient in the hospital who is infected or colonized with MRSA), race, and 
economic status (Salgado, Farr, & Calfee, 2003; Li et al., 2005b).  The changing 
resistance rates from 2003 to 2005 indicate that studies need to be done periodically to 
keep up with changes in resistance rates over time.   
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Appendix 1 
 
A-1.  Estimated April 1, 2005 Population For the Counties In Florida Based on the 2000 
Census (BEBR 4/1/2005 Population for Counties, n.d.). 
 
County Estimated Population County Estimated Population 
ALACHUA 240,764 LEE 549,442 
BAKER 23,953 LEON 271,111 
BAY 161,721 LEVY 37,985 
BRADFORD 28,118 LIBERTY 7,581 
BREVARD 531,970 MADISON 19,696 
BROWARD 1,740,987 MANATEE 304,364 
CALHOUN 13,945 MARION 304,926 
CHARLOTTE 154,030 MARTIN 141,059 
CITRUS 132,635 MIAMI-DADE 2,422,075 
CLAY 169,623 MONROE 82,413 
COLLIER 317,788 NASSAU 65,759 
COLUMBIA 61,466 OKALOOSA 188,939 
DE SOTO 32,606 OKEECHOBEE 37,765 
DIXIE 15,377 ORANGE 1,043,437 
DUVAL 861,150 OSCEOLA 235,156 
ESCAMBIA 303,623 PALM BEACH 1,265,900 
FLAGLER 78,617 PASCO 406,898 
FRANKLIN 10,845 PINELLAS 947,744 
GADSDEN 47,713 POLK 541,840 
GILCHRIST 16,221 PUTNAM 73,764 
GLADES 10,729 ST. JOHNS 157,278 
GULF 16,479 ST. LUCIE 240,039 
HAMILTON 14,315 SANTA ROSA 136,443 
HARDEE 27,333 SARASOTA 367,867 
HENDRY 38,376 SEMINOLE 411,744 
HERNANDO 150,784 SUMTER 74,052 
HIGHLANDS 93,456 SUWANNEE 38,174 
HILLSBOROUGH 1,131,546 TAYLOR 21,310 
HOLMES 19,157 UNION 15,046 
INDIAN RIVER 130,043 VOLUSIA 494,649 
JACKSON 49,691 WAKULLA 26,867 
JEFFERSON 14,233 WALTON 53,525 
LAFAYETTE 7,971 WASHINGTON 23,097 
LAKE 263,017 FLORIDA 17,918,227 
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A-2.  Estimated April 1, 2005 Population For the Seven Regions of Florida Based on the 
2000 Census. (BEBR 4/1/2005 Population for Counties, n.d.). 
 
Region Estimated Population
1 966,620 
2 556,659 
3 2,073,204 
4 3,717,196 
5 3,491,114 
6 1,602,059 
7 5,511,375 
 
 
 
 
